AI assistant
Altek — Audit Report / Information 2022
Nov 15, 2022
52290_rns_2022-11-15_a962a858-0cc5-44a2-9c87-8b39df7c5d41.pdf
Audit Report / Information
Open in viewerOpens in your device viewer
ALTEK CORPORATION
PARENT COMPANY ONLY FINANCIAL
STATEMENTS AND INDEPENDENT AUDITORS’
REPORT
DECEMBER 31, 2022 AND 2021 (Stock Code : 3059)
For the convenience of readers and for information purpose only, the auditors’ report and the accompanying financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. In the event of any discrepancy between the English version and the original Chinese version or any differences in the interpretation of the two versions, the Chinese-language auditors’ report and financial statements shall prevail.
~1~
INDEPENDENT AUDITORS’ REPORT TRANSLATED FROM CHINESE
PWCR22000230
To the Board of Directors and Shareholders of ALTEK CORPORATION
Opinion
We have audited the accompanying parent company only balance sheets of ALTEK CORPORATION as of December 31, 2022 and 2021, and the related parent company only statements of comprehensive income, of changes in equity and of cash flows for the years then ended, and the notes to the parent company only financial statements, including a summary of significant accounting policies.
In our opinion, the accompanying parent company only financial statements present fairly, in all material respects, the financial position of ALTEK CORPORATION as of December 31, 2022 and 2021, and its financial performance and its cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the Financial Supervisory Commission.
Basis for opinion
We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and Standards of Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the audit of the parent company only financial statements section of our report. We are independent of ALTEK CORPORATION in accordance with the Norm of Professional Ethics for Certified Public Accountants of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
~2~
Key audit matters
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of ALTEK CORPORATION’s 2022 the parent company only financial statements of the current period. These matters were addressed in the context of our audit of the parent company only financial statements as a whole and, in forming our opinion thereon, we do not provide a separate opinion on these matters.
Key audit matters for ALTEK CORPORATION’s 2022 the parent company only financial statements of the current period are stated as follows:
Allowance for inventory valuation losses
Description
Please refer to Note 4(12) for description of accounting policy on inventory valuation. Please refer to Note 5(2) for accounting estimates and assumption uncertainty in relation to inventory valuation. Please refer to Note 6(5) for the details of inventories.
ALTEK CORPORATION’s subsidiaries (shown as Investments accounted for under the equity method) are primarily engaged in manufacturing and sales of automobile cameras, medical and digital image application products. The subsidiaries measures inventories sold at the lower of cost and net realisable value. For inventory that is over a certain age and individually identified obsolete or damaged inventory, the subsidiaries recognises losses at net realisable value. The value of inventories is significant, involves various types of inventory, and the individual identification of inventory usually involves management judgement which is an area that also needs to be assessed using our judgement during the audit process. Thus, we identified the subsidiaries’ valuation of allowance for inventory losses as one of the key audit matters.
How our audit addressed the matter
We performed the following audit procedures on the above key audit matter:
-
A. Obtained an understanding and assessed the provision policy on inventory valuation losses.
-
B. Obtained the statement of individually identified obsolete inventory prepared by management and checked the accuracy of stock age analysis report and relevant information.
~3~
- C. Checked the accuracy of net realisable value of inventory, assessed the consistency between valuation of market value decline and its provision policy, and assessed the reasonableness of allowance for valuation losses determined by the Company.
Recognition of sales revenue
Description
Please refer to Note 4(27) for accounting policies of revenue recognition. Please refer to Note 6(21) for the details of sales revenue. Sales revenue is the main operating activity and relevant to ALTEK CORPORATION’s financial performance. ALTEK CORPORATION has many customers, the recognition of sales revenue require judgment in determining the transfer of control of goods. Therefore, we identified the recognition of sales revenue as one of the key audit matters.
How our audit addressed the matter
We performed the following audit procedures on the above key audit matter:
-
A. Assessed the appropriateness of policies on sales revenue recognition.
-
B. Assessed and tested the design of internal controls that are relevant to sales revenue recognition and the effectiveness of execution.
-
C. Sampled and validated transaction terms, performance obligations, prices, orders, shipping documents and assessed appropriateness of amount and timing of revenue recognition.
Responsibilities of management and those charged with governance for the parent
company only financial statements
Management is responsible for the preparation and fair presentation of the parent company only financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the Financial Supervisory Commission, and for such internal control as management determines is necessary to enable the preparation of parent company only financial statements that are free from material misstatement, whether due to fraud or error.
~4~
In preparing the parent company only financial statements, management is responsible for assessing ALTEK CORPORATION’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate ALTEK CORPORATION or to cease operations, or has no realistic alternative but to do so.
Those charged with governance, including the audit committee, are responsible for overseeing ALTEK CORPORATION’s financial reporting process.
Auditor’s responsibilities for the audit of the parent company only financial statements
Our objectives are to obtain reasonable assurance about whether the parent company only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but it is not a guarantee that an audit conducted in accordance with Standards of Auditing of the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these parent company only financial statements.
As part of an audit in accordance with Standards of Auditing of the Republic of China, we exercise professional judgment and professional skepticism throughout the audit. We also:
-
A. Identify and assess the risks of material misstatement of the parent company only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
-
B. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of ALTEK CORPORATION’s internal control.
~5~
-
C. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
-
D. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on ALTEK CORPORATION’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the parent company only financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause ALTEK CORPORATION to cease to continue as a going concern.
-
E. Evaluate the overall presentation, structure and content of the parent company only financial statements, including the disclosures, and whether the parent company only financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
-
F. Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within ALTEK CORPORATION to express an opinion on the parent company only financial statements. We are responsible for the direction, supervision and performance of ALTEK CORPORATION’s audit. We remain solely responsible for our audit opinion.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
~6~
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the parent company only financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.
Hsieh, Chin-Cheng
[Chiang, Tsai-Yen ]
For and on behalf of PricewaterhouseCoopers, Taiwan March 10, 2023
------------------------------------------------------------------------------------------------------------------------------------------------The accompanying parent company only financial statements are not intended to present the financial position and results of operations and cash flows in accordance with accounting principles generally accepted in countries and jurisdictions other than the Republic of China. The standards, procedures and practices in the Republic of China governing the audit of such financial statements may differ from those generally accepted in countries and jurisdictions other than the Republic of China. Accordingly, the accompanying parent company only financial statements and report of independent accountants are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice.
As the financial statements are the responsibility of the management, PricewaterhouseCoopers cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.
~7~
ALTEK CORPORATION
PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars)
| Assets | Notes 6(1) 6(4) 6(4) and 7 7 6(5) 6(2) 6(3) 6(6) 6(7) and 8 6(8) 6(9) and 8 6(10) 6(28) |
December 31, 2022 AMOUNT % $744,10851,172,1878737-6,509-83,829146-237,720116,278-2,485-2,263,8991583,6011--10,512,355701,243,059894,4361743,07052,764-77,596-30,223-12,787,10485$15,051,003100 |
December 31, 2021 | December 31, 2021 |
|---|---|---|---|---|
AMOUNT$744,1081,172,1877376,50983,82946237,72016,2782,4852,263,89983,601-10,512,3551,243,05994,436743,0702,76477,59630,22312,787,104$15,051,003 |
AMOUNT$684,671914,6192,7045,54788,171326164,42921,4192,2511,884,13779,184-9,429,8991,274,154104,039750,0974,144157,57930,57811,829,674$13,713,811 |
% | ||
| Current assets 1100 Cash and cash equivalents 1170 Accounts receivable, net 1180 Accounts receivable - related parties 1200 Other receivables 1210 Other receivables - related parties 1220 Current income tax assets 130X Inventories, net 1410 Prepayments 1470 Other current assets 11XX Current Assets Non-current assets 1510 Non-current financial assets at fair value through profit or loss 1517 Non-current financial assets at fair value through other comprehensive income 1550 Investments accounted for under the equity method 1600 Property, plant and equipment 1755 Right-of-use assets 1760 Investment property - net 1780 Intangible assets 1840 Deferred income tax assets 1900 Other non-current assets 15XX Non-current assets 1XXX Total assets |
57--1-1-- |
|||
14 |
||||
1-69915-1- |
||||
86 |
||||
100 |
(Continued)
~8~
ALTEK CORPORATION
PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars)
| Liabilities and Equity | December 31, 2022 December 31, 2021 Notes AMOUNT % AMOUNT % 6(11) $1,848,00012$2,400,000186(12) 399,6693599,81846(21) 68,815-2,483-118,261136,978-7 1,669,932111,193,3419301,7142210,48627 241,456213,380-2,310---6(16) 32,346-9,305-8,395-9,498-6(13) 500,0003--7 373,974315,503-5,564,872374,490,792336(16) 29,350-29,350-6(28) 494,3363482,818388,024196,03816(14) 11,360-13,301-623,0704621,50746,187,942415,112,299376(17) 2,788,180182,792,011216(18) 2,046,625142,392,215176(19) 1,441,00291,418,41010774,8325651,55652,366,630162,266,140176(20) (516,107) (3) (787,359) (6 )6(17) (38,101)- (131,461) (1 )8,863,061598,601,5126311 $15,051,003100$13,713,811100 |
|---|---|
| Current liabilities 2100 Short-term borrowings 2110 Short-term notes and bills payable 2130 Current contract liabilities 2170 Accounts payable 2180 Accounts payable - related parties 2200 Other payables 2220 Other payables - related parties 2230 Current income tax liabilities 2250 Provisions for liabilities - current 2280 Current lease liabilities 2320 Long-term liabilities, current portion 2399 Other current liabilities, others 21XX Current Liabilities Non-current liabilities 2550 Provisions for liabilities - non-current 2570 Deferred income tax liabilities 2580 Non-current lease liabilities 2600 Other non-current liabilities 25XX Non-current liabilities 2XXX Total Liabilities Equity Share capital 3110 Common stock Capital surplus 3200 Capital surplus Retained earnings 3310 Legal reserve 3320 Special reserve 3350 Unappropriated retained earnings Other equity interest 3400 Other equity interest 3500 Treasury stocks 3XXX Total equity Significant events after the balance sheet date 3X2X Total liabilities and equity |
The accompanying notes are an integral part of these parent company only financial statements.
~9~
ALTEK CORPORATION PARENT COMPANY ONLY STATEMENTS OF COMPREHENSIVE INCOME YEARS ENDED DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars, except earnings per share amounts)
| Items | Year ended December 31 2022 2021 Notes AMOUNT % AMOUNT % 6(21) and 7 $9,493,624100$5,105,4881006(5)(26)(27) and 7 (8,798,660) (93) (4,634,033) (91)694,9647471,45596(26)(27) and 7 (30,323)-(23,405)-(303,393) (3) (298,898) (6)(453,130) (5) (354,883) (7)12(2) (143)-46-(786,989) (8) (677,140) (13)(92,025) (1) (205,685) (4)6(22) 1,039-661-6(23) and 7 30,951-29,48816(24) 75,383136,22816(25) (34,964)-(25,517) (1)6(6) 498,5385410,6658570,9476451,5259478,9225245,84056(28) (22,180)-(21,106) (1)$456,7425$224,73446(14) $206-$3,433-(27,284)-(21,154)-6(28) (41)-(942)-(27,119)-(18,663)-358,3804(129,298) (3)6(28) (71,676) (1)25,8601286,7043(103,438) (2)$259,5853($122,101) (2)$716,3278$102,63326(29) $1.67$0.856(29) $1.65$0.83 |
|---|---|
| 4000 Operating revenue 5000 Operating costs 5900 Net operating margin Operating expenses 6100 Selling expenses 6200 General and administrative expenses 6300 Research and development expenses 6450 Expected credit gains 6000 Total operating expenses 6900 Operating loss Non-operating income and expenses 7100 Interest income 7010 Other income 7020 Other gains and losses 7050 Finance costs 7070 Share of profit of associates and joint ventures accounted for using equity method, net 7000 Total non-operating income and expenses 7900 Profit before income tax 7950 Income tax expense 8200 Profit for the year Other comprehensive income Components of other comprehensive income (loss) that will not be reclassified to profit or loss 8311 Other comprehensive income, before tax, actuarial gains on defined benefit plans 8316 Unrealised losses from investments in equity instruments measured at fair value through other comprehensive income 8349 Income tax related to components of other comprehensive income that will not be reclassified to profit or loss 8310 Components of other comprehensive income that will not be reclassified to profit or loss Components of other comprehensive (loss) income that will be reclassified to profit or loss 8361 Other comprehensive loss, before tax, exchange differences on translation 8399 Income tax relating to the components of other comprehensive income 8360 Components of other comprehensive income that will be reclassified to profit or loss 8300 Other comprehensive income (loss) for the year 8500 Total comprehensive income for the year 9750 Basic earnings per share 9850 Diluted earnings per share |
The accompanying notes are an integral part of these parent company only financial statements.
~10~
ALTEK CORPORATION
PARENT COMPANY ONLY STATEMENTS OF CHANGES IN EQUITY YEARS ENDED DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars)
| 2021 Balance at January 1, 2021 Profit for the year Other comprehensive income (loss) for the year Total comprehensive income (loss) Appropriation of 2020 earnings Legal reserve Special reserve Cash dividend Share-based payment transactions Retirement of employee restricted shares Treasury stock transferred to employees Changes in ownership interest in subsidiaries Proceeds from disposal of financial assets at fair value through other comprehensive income Balance at December 31, 2021 2022 Balance at January 1, 2022 Profit for the year Other comprehensive income (loss) for the year Total comprehensive income (loss) Appropriation of 2021 earnings Legal reserve Special reserve Cash dividend Share-based payment transactions Retirement of employee restricted shares Treasury stock transferred to employees Changes in ownership interest in subsidiaries Balance at December 31, 2022 |
Notes | Common stock | Capital surplus | Retained earnings | Retained earnings | Other equityint | Other equityint | ere | st | Treasurystocks | Total equity | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Legal reserve | Special reserve | Unappropriated retained earnings |
Currency translation differences of foreign operations |
Other | |||||||||||||||
| 6(20) 6(19) 6(15)(18)(20) 6(15)(17)(18)(20) 6(17)(18) 6(18) 6(20) 6(20) 6(19) 6(15)(18)(20) 6(15)(17)(18)(20) 6(17)(18) 6(18) |
$2,794,973-------(2,962 ) ---$2,792,011$2,792,011-------(3,831 ) --$2,788,180 |
$2,335,226------69,940(3,722 ) (227 ) (9,002 ) -$2,392,215$2,392,215------50,109(4,917 ) (341 ) (390,441 ) $2,046,625 |
$ 1,402,467---15,943-------$ 1,418,410$ 1,418,410---22,592------$ 1,441,002 |
$592,325----59,231------$651,556$651,556----123,276-----$774,832 |
$2,249,655224,7342,746227,480(15,943 ) (59,231 ) (134,249 ) ----(1,572 ) $2,266,140$2,266,140456,742165456,907(22,592 ) (123,276 ) (190,401 ) ---(20,148 ) $2,366,630 |
($550,536 )-(103,438 )(103,438 )--------($653,974 )($653,974 )-286,704286,704-------($367,270 ) |
($147,162 )-(21,409 )(21,409 )---26,9306,684--1,572($133,385 )($133,385 )-(27,284 )(27,284 )---3,0848,748--($148,837 ) |
($ 209,287 ) --------77,826--($ 131,461 ) ($ 131,461 ) --------93,360-($38,101 ) |
$ 8,467,661224,734(122,101 )102,633--(134,249 )96,870-77,599(9,002 )-$ 8,601,512$ 8,601,512456,742259,585716,327--(190,401 )53,193-93,019(410,589 )$ 8,863,061 |
The accompanying notes are an integral part of these parent company only financial statements.
~11~
ALTEK CORPORATION
PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS YEARS ENDED DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars)
| CASH FLOWS FROM OPERATING ACTIVITIES Profit before tax Adjustments Adjustments to reconcile profit (loss) Depreciation Amortization Expected credit loss (gains) Net gain on financial assets at fair value through profit Interest expense Interest income Dividend income Share-based payment compensation cost Profit on investments accounted for under the equity method Changes in operating assets and liabilities Changes in operating assets Accounts receivable Accounts receivable-related parties Other receivables Other receivables-related parties Inventories Prepayments Other current assets Changes in operating liabilities Current contract liabilities Accounts payable Accounts payable - related parties Other payables Other payables-related parties Provision of liabilities Other current liabilities Other non-current liabilities Cash inflow (outflow) generated from operations Interest received Dividend received Interest paid Income tax received Net cash flows from operating activities |
Year ended December 31 Notes 2022 2021 $478,922 $245,8406(7)(8)(9)(26) 51,74054,4686(10)(26) 2,8433,77812(2) 143 ( 46 )6(2)(24) ( 4,417 ) ( 30,955 )6(25) 34,96425,5176(22) ( 1,039 ) ( 661 )6(23) ( 2,289 ) ( 1,526 )6(15) 52,33985,9766(6) ( 498,538 ) ( 410,665 )( 257,711 ) ( 228,674 )1,96710,973( 962 ) ( 3,762 )5,197 ( 15,461 )( 73,291 ) ( 89,397 )5,141 ( 10,603 )( 234 ) ( 847 )66,3321,50281,2835,119476,591297,69590,76629,404228,0764,54923,041 ( 27,696 )12,871 ( 6,656 )( 1,735 ) 19772,000 ( 62,109 )1,03966994,149209,876( 29,610 ) ( 21,274 )1942,313837,772129,475 |
|---|---|
(Continued)
~12~
ALTEK CORPORATION
PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS YEARS ENDED DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars)
| CASH FLOWS FROM INVESTING ACTIVITIES Acquisition of investment accounted for under the equity method Acquisition of property, plant, and equipment Increase in advance receipts - disposal of assets Acquisition of intangible assets Decrease in guarantee deposits paid Net cash flows used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from short-term borrowings Repayment of short-term borrowings Proceeds from issuance of short-term notes and bills payable Repayment of short-term notes and bills payable Proceeds from long-term borrowings Repayment of long-term borrowings Increase in guanrantee deposits received Repayment of principal portion of lease liabilities Cash dividends paid Treasury shares transferred to employees Net cash flows (used in) from financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year |
Year ended December 31 Notes 2022 2021 ($755,272 ) $-6(30) ( 3,777 ) ( 9,403 )345,600-6(30) ( 1,669 ) ( 2,376 )3551,851( 414,763 ) ( 9,928 )6(31) 15,132,00016,110,0006(31) ( 15,684,000 ) ( 16,040,000 )6(31) 3,696,4003,097,1946(31) ( 3,900,000 ) ( 2,800,000 )6(31) 500,000-6(31) - ( 250,000 )6(31) -96(31) ( 10,590 ) ( 11,833 )6(19) ( 190,401 ) ( 134,249 )93,01977,599( 363,572 ) 48,72059,437168,2676(1) 684,671516,4046(1) $744,108 $684,671 |
|---|---|
The accompanying notes are an integral part of these parent company only financial statements.
~13~
ALTEK CORPORATION NOTES TO THE PARENT COMPANY ONLY FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)
1. HISTORY AND ORGANIZATION
Altek Corporation (the “Company”) was incorporated as a company limited by shares under the provisions of the Company Law of the Republic of China (R.O.C.). The Company is primarily engaged in the development, manufacturing and sale of automobile cameras, medical and digital image technology application products, and related export and import trade.
The Company was listed in the Taiwan Stock Exchange on December 24, 2002, as approved by the TaiTz (91) Letter No. 024976 of the former Securities and Futures Commission, Ministry of Finance, R.O.C., dated September 27, 2002.
- THE DATE OF AUTHORISATION FOR ISSUANCE OF THE FINANCIAL STATEMENTS AND
PROCEDURES FOR AUTHORISATION
The parent company only financial statements were authorized for issuance by the Board of Directors on March 10, 2023.
3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS
(1) Effect of the adoption of new issuances of or amendments to International Financial Reporting Standards (“IFRS”) that came into effect as endorsed by the Financial Supervisory Commission (“FSC”)
New standards, interpretations and amendments that came into effect as endorsed by FSC effective from 2022 are as follows:
| (2) | New Standards, Interpretations and Amendments |
|---|---|
New standards, interpretations and amendments that came into effect as endorsed by the FSC effective from 2023 are as follows:
~14~
| Effective date by | |
|---|---|
| International Accounting | |
| New Standards,Interpretations and Amendments | Standards Board |
| Amendments to IAS 1, ‘Disclosure of accounting policies’ | January 1, 2023 |
| Amendments to IAS 8, ‘Definition of accounting estimates’ | January 1, 2023 |
| Amendments to IAS 12, ‘Deferred tax related to assets and liabilities | January 1, 2023 |
| arising from a single transaction’ |
Except for the following, the above standards and interpretations have no significant impact to the Company’s financial condition and financial performance based on the Company’s assessment.
(3) IFRSs issued by IASB but not yet endorsed by the FSC
New standards, interpretations and amendments issued by IASB but not yet included in the IFRSs as endorsed by the FSC are as follows:
| endorsed by the FSC are as follows: | |
|---|---|
| Effective date by | |
| International Accounting | |
| New Standards,Interpretations andAmendments | StandardsBoard |
| Amendments to IFRS 10 and IAS 28, ‘Sale or contribution of assets | To be determined by |
| between an investor and its associate or joint venture’ | International Accounting |
| Standards Board | |
| Amendments to IFRS 16, ‘Lease liability in a sale and leaseback’ | January 1, 2024 |
| IFRS 17, ‘Insurance contracts’ | January 1, 2023 |
| Amendments to IFRS 17, 'Insurance contracts' | January 1, 2023 |
| Amendment to IFRS 17, 'Initial application of IFRS 17 and IFRS 9 – | January 1, 2023 |
| comparative information' | |
| Amendments to IAS 1, ‘Classification of liabilities as current or non- | January 1, 2024 |
| current’ | |
| Amendments to IAS 1, ‘Non-current liabilities with covenants’ | January 1, 2024 |
The above standards and interpretations have no significant impact to the Company’s financial condition and financial performance based on the Company’s assessment.
4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these accompanying parent company only
financial statements are set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.
(1) Compliance statement
The parent company only financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers.
(2) Basis of preparation
-
A. Except for the following items, the parent company only financial statements have been prepared under the historical cost convention:
-
(a) Financial assets and financial liabilities (including derivative instruments) at fair value through
~15~
profit or loss.
- (b) Financial assets at fair value through other comprehensive income.
- (c) Defined benefit liabilities recognised based on the net amount of pension fund assets less present value of defined benefit obligation.
-
B. The preparation of financial statements in conformity with International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the FSC (collectively referred herein as the “IFRSs”) requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the parent company only financial statements are disclosed in Note 5.
-
(3) Foreign currency translation
Items included in the financial statements of the Company’s entities are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”). The parent company only financial statements are presented in New Taiwan Dollar, which is the Company’s functional currency.
-
A. Foreign currency transactions and balances
-
(a) Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions or valuation where items are remeasured. Foreign exchange gains and losses resulting from the settlement of such transactions are recognised in profit or loss in the period in which they arise.
-
(b) Monetary assets and liabilities denominated in foreign currencies at the period end are retranslated at the exchange rates prevailing at the balance sheet date. Exchange differences arising upon re-translation at the balance sheet date are recognised in profit or loss.
-
(c) Non-monetary assets and liabilities denominated in foreign currencies held at fair value through profit or loss are re-translated at the exchange rates prevailing at the balance sheet date; their translation differences are recognised in profit or loss. Non-monetary assets and liabilities denominated in foreign currencies held at fair value through other comprehensive income are re-translated at the exchange rates prevailing at the balance sheet date; their translation differences are recognised in other comprehensive income. However, nonmonetary assets and liabilities denominated in foreign currencies that are not measured at fair value are translated using the historical exchange rates at the dates of the initial transactions.
-
(d) All foreign exchange gains and losses are presented in the statement of comprehensive income within “other gains and losses”.
~16~
-
B. Translation of foreign operations
-
(a) The operating results and financial position of all the subsidiaries, associates and joint arrangements that have a functional currency different from the presentation currency are translated into the presentation currency as follows:
-
i. Assets and liabilities for each balance sheet presented are translated at the closing exchange rate at the date of that balance sheet;
-
ii. Income and expenses for each statement of comprehensive income are translated at average exchange rates of that period; and
-
iii. All resulting exchange differences are recognised in other comprehensive income.
-
-
(b) When the foreign operation partially disposed of or sold is an associate or joint arrangement, exchange differences that were recorded in other comprehensive income are proportionately reclassified to profit or loss as part of the gain or loss on sale. In addition, even when the Company retains partial interest in the former foreign associate or joint arrangement after losing significant influence over the former foreign associate, or losing joint control of the former joint arrangement, such transactions should be accounted for as disposal of all interest in these foreign operations.
-
(c) When the foreign operation partially disposed of or sold is a subsidiary, cumulative exchange differences that were recorded in other comprehensive income are proportionately transferred to the non-controlling interest in this foreign operation. In addition, even when the Company retains partial interest in the former foreign subsidiary after losing control of the former foreign subsidiary, such transactions should be accounted for as disposal of all interest in the foreign operation.
-
(d) Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and translated at the closing exchange rates at the balance sheet date.
(4) Classification of current and non-current items
-
A. Assets that meet one of the following criteria are classified as current assets; otherwise they are classified as non-current assets:
-
(a) Assets arising from operating activities that are expected to be realised, or are intended to be sold or consumed within the normal operating cycle;
-
(b) Assets held mainly for trading purposes;
-
(c) Assets that are expected to be realised within twelve months from the balance sheet date;
-
(d) Cash and cash equivalents, excluding restricted cash and cash equivalents and those that are to be exchanged or used to settle liabilities more than twelve months after the balance sheet date.
-
B. Liabilities that meet one of the following criteria are classified as current liabilities; otherwise they are classified as non-current liabilities:
-
(a) Liabilities that are expected to be settled within the normal operating cycle;
-
(b) Liabilities arising mainly from trading activities;
~17~
- (c) Liabilities that are to be settled within twelve months from the balance sheet date;
- (d) Liabilities for which the repayment date cannot be extended unconditionally to more than twelve months after the balance sheet date. Terms of a liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.
-
(5) Cash equivalents
-
Cash equivalents refer to short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. Time deposits that meet the definition above and are held for the purpose of meeting short-term cash commitments in operations are classified as cash equivalents.
-
(6) Financial assets at fair value through profit or loss
-
A. Financial assets at fair value through profit or loss are financial assets that are not measured at amortised cost or fair value through other comprehensive income.
-
B. On a regular way purchase or sale basis, financial assets at fair value through profit or loss are recognised and derecognised using settlement date accounting.
-
C. At initial recognition, the Company measures the financial assets at fair value and recognises the transaction costs in profit or loss. The Company subsequently measures the financial assets at fair value, and recognises the gain or loss in profit or loss.
-
D. The Company recognises the dividend income when the right to receive payment is established, future economic benefits associated with the dividend will flow to the Company and the amount of the dividend can be measured reliably.
-
(7) Financial assets at fair value through other comprehensive income
-
A. Financial assets at fair value through other comprehensive income comprise equity securities which are not held for trading, and for which the Company has made an irrevocable election at initial recognition to recognise changes in fair value in other comprehensive income.
-
B. On a regular way purchase or sale basis, financial assets at fair value through other comprehensive income are recognised and derecognised using settlement date accounting.
-
C. At initial recognition, the Company measures the financial assets at fair value plus transaction costs. The Company subsequently measures the financial assets at fair value: The changes in fair value of equity investments that were recognised in other comprehensive income are reclassified to retained earnings and are not reclassified to profit or loss following the derecognition of the investment. Dividends are recognised as revenue when the right to receive payment is established, future economic benefits associated with the dividend will flow to the Company and the amount of the dividend can be measured reliably.
(8) Accounts receivable
- A. Accounts receivable entitle the Company a legal right to receive consideration in exchange for transferred goods or rendered services.
~18~
-
B. The short-term accounts receivable without bearing interest are subsequently measured at initial invoice amount as the effect of discounting is immaterial.
-
(9) Impairment of financial assets
-
For financial assets at amortised cost at each reporting date, the Company recognises the impairment provision for 12 months expected credit losses if there has not been a significant increase in credit risk since initial recognition or recognises the impairment provision fot the lifetime expected credit losses (ECLs) if such credit erisk has increased since initial recognition after taking into consideration all reasonable and verifiable information that includes forecasts. On the other hand, for accounts receivable that does not contain a significant financing component, the Company recognises the impairment provision for lifetime ECLs.
(10) Derecognition of financial assets
- The Company derecognises a financial asset when the contractual rights to receive the cash flows from the financial asset expire.
The Company derecognises a financial asset when one of the following conditions is met:
-
A. The contractual rights to receive the cash flows from the financial asset expire.
-
B. The contractual rights to receive cash flows of the financial asset have been transferred and the Company has transferred substantially all risks and rewards of ownership of the financial asset.
-
C. The contractual rights to receive cash flows of the financial asset have been transferred; however, the Company has not retained control of the financial asset.
-
- -
(11) Leasing arrangements (lessor) operating leases
Lease income from an operating lease (net of any incentives given to the lessee) is recognised in profit or loss on a straight-line basis over the lease term.
-
(12) Inventories
-
Inventories are stated at the lower of cost and net realisable value. Cost is determined using the weighted-average method. The cost of finished goods and work in progress comprises raw materials, direct labour, other direct costs and related production overheads (allocated based on normal operating capacity). It excludes borrowing costs. The item by item approach is used in applying the lower of cost and net realisable value. Net realisable value is the estimated selling price in the ordinary course of business, less the estimated cost of completion and the estimated costs necessary to make the sale.
(13) Investments accounted for using equity method / subsidiaries
-
A. Subsidiaries are all entities controlled by the Company. The Company controls an entity when the Company is exposed, or has rights, to variable returns from its involvement with the entity and has ability to affect those returns through its power over the entity.
-
B. Unrealised profit (loss) that occurred from the transactions between the Company and subsidiaries have been offset. The accounting policies of the subsidiaries have been adjusted where necessary to ensure consistency with the policies adopted by the Company.
-
C. The Company’s share of its subsidiaries’ post-acquisition profits or losses is recognised in profit
~19~
or loss, and its share of post-acquisition movements in other comprehensive income is recognised in other comprehensive income. When the Company’s share of losses in a subsidiary equals or exceeds its interest in the subsidiary, the Company continues to recognise its share in the subsidiary’s loss proportionately.
-
D. Changes in a parent’s ownership interest in a subsidiary that do not result in the parent losing control of the subsidiary (transactions with non-controlling interests) are accounted for as equity transactions, i.e. transactions with owners in their capacity as owners. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recognised directly in equity.
-
E. Pursuant to the “Regulations Governing the Preparation of Financial Reports by Securities Issuers,” profit (loss) of the current period and other comprehensive income in the nonconsolidated financial statements shall equal to the amount attributable to owners of the parent in the financial statements prepared with basis for consolidation. Owners’ equity in the nonconsolidated financial statements shall equal to equity attributable to owners of the parent in the financial statements prepared with basis for consolidation.
-
(14) Property, plant and equipment
-
A. Property, plant and equipment are initially recorded at cost. Borrowing costs incurred during the construction period are capitalised.
-
B. Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognised. All other repairs and maintenance are charged to profit or loss during the financial period in which they are incurred.
-
C. Land is not depreciated. Other property, plant and equipment apply cost model and are depreciated using the straight-line method to allocate their cost over their estimated useful lives. Each part of an item of property, plant, and equipment with a cost that is significant in relation to the total cost of the item must be depreciated separately.
-
D. The assets’ residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each financial year-end. If expectations for the assets’ residual values and useful lives differ from previous estimates or the patterns of consumption of the assets’ future economic benefits embodied in the assets have changed significantly, any change is accounted for as a change in estimate under IAS 8, ‘Accounting Policies, Changes in Accounting Estimates and Errors’, from the date of the change. The estimated useful lives of property, plant and equipment are as follows:
| are as follows: | ||
|---|---|---|
| Buildings and structures | 3 ~ | 40 years |
| Machinery and equipment | 4 years | |
| Utility equipment | 3 ~ | 6 years |
| Other equipment | 2 ~ | 11 years |
~20~
(15) Leasing arrangements (lessee) - right-of-use assets/ lease liabilities
-
A. Leases are recognised as a right-of-use asset and a corresponding lease liability at the date at which the leased asset is available for use by the Company. For short-term leases or leases of low-value assets, lease payments are recognised as an expense on a straight-line basis over the lease term.
-
B. Lease liabilities include the net present value of the remaining lease payments at the commencement date, discounted using the incremental borrowing interest rate.
-
The Company subsequently measures the lease liability at amortised cost using the interest method and recognises interest expense over the lease term. The lease liability is remeasured and the amount of remeasurement is recognised as an adjustment to the right-of-use asset when there are changes in the lease term or lease payments and such changes do not arise from contract modifications.
-
C. At the commencement date, the right-of-use asset is stated at cost comprising the following: (a) The amount of the initial measurement of lease liability
-
(b) Any initial direct costs incurred by the lessee
The right-of-use asset is measured subsequently using the cost model and is depreciated from the commencement date to the earlier of the end of the asset’s useful life or the end of the lease term. When the lease liability is remeasured, the amount of remeasurement is recognised as an adjustment to the right-of-use asset.
(16) Investment property
An investment property is stated initially at its cost and measured subsequently using the cost model. Except for land, investment property is depreciated on a straight-line basis over its estimated useful life of 10 ~ 35 years.
(17) Intangible assets
Computer software are stated at cost and amortised on a straight-line basis over its estimated useful lives of 1 ~ 3 years.
(18) Impairment of non-financial assets
The Company assesses at each balance sheet date the recoverable amounts of those assets where there is an indication that they are impaired. An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell or value in use. Except for goodwill, when the circumstances or reasons for recognising impairment loss for an asset in prior years no longer exist or diminish, the impairment loss is reversed. The increased carrying amount due to reversal should not be more than what the depreciated or amortised historical cost would have been if the impairment had not been recognised.
(19) Borrowings
Borrowings comprise long-term and short-term bank borrowings. Borrowings are recognised initially at fair value, net of transaction costs incurred.
~21~
(20) Notes and accounts payable
-
A. Accounts payable are liabilities for purchases of raw materials, goods or services and notes payable are those resulting from operating and non-operating activities.
-
B. The Company initially measures notes and accounts payable at fair value and subsequently amortises the interest expense in profit or loss over the period of circulation using the effective interest method.
(21) Provisions
Provisions (warranties) are recognised when the Company has a present legal or constructive obligation as a result of past events, and it is probable that an outflow of economic resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation on the balance sheet date.
(22) Employee benefits
- A. Short-term employee benefits
Short-term employee benefits are measured at the undiscounted amount of the benefits expected to be paid in respect of service rendered by employees in a period and should be recognised as expense in that period when the employees render service.
-
B. Pensions
-
(a) Defined contribution plans
For defined contribution plans, the contributions are recognised as pension expense when they are due on an accrual basis. Prepaid contributions are recognised as an asset to the extent of a cash refund or a reduction in the future payments.
-
(b) Defined benefit plans
-
i. Net obligation under a defined benefit plan is defined as the present value of an amount of pension benefits that employees will receive on retirement for their services with the Company in current period or prior periods. The liability recognised in the balance sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The net defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method. The rate used to discount is determined by using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating to the terms of the related pension liability; when there is no deep market in high-quality corporate bonds, the Company uses interest rates of government bonds (at the balance sheet date) instead.
-
ii. Remeasurements arising on defined benefit plans are recognised in other comprehensive income in the period in which they arise and are recorded as retained earnings.
-
iii. Past service costs are recognised immediately in profit or loss.
~22~
C. Termination benefits
- Termination benefits are employee benefits provided in exchange for the termination of employment as a result from either the Company’s decision to terminate an employee’s employment before the normal retirement date, or an employee’s decision to accept an offer of redundancy benefits in exchange for the termination of employment. The Company recognises expense as it can no longer withdraw an offer of termination benefits or it recognises relating restructuring costs, whichever is earlier. Benefits that are expected to be due more than 12 months after balance sheet date shall be discounted to their present value.
-
D. Employees’ compensation and directors’ remuneration Employees’ compensation and directors’ remuneration are recognised as expense and liability, provided that such recognition is required under legal or constructive obligation and those amounts can be reliably estimated. Any difference between the resolved amounts and the subsequently actual distributed amounts is accounted for as changes in estimates. If employee compensation is paid by shares, the Company calculates the number of shares based on the closing price at the previous day of the board meeting resolution.
-
(23) Employee share based payment
-
A. For the equity-settled share-based payment arrangements, the employee services received are measured at the fair value of the equity instruments granted at the grant date, and are recognised as compensation cost over the vesting period, with a corresponding adjustment to equity. The fair value of the equity instruments granted shall reflect the impact of market vesting conditions and non-vesting conditions. Compensation cost is subject to adjustment based on the service conditions that are expected to be satisfied and the estimates of the number of equity instruments that are expected to vest under the non-market vesting conditions at each balance sheet date. Ultimately, the amount of compensation cost recognised is based on the number of equity instruments that eventually vest.
-
B. Restricted stocks:
-
(a) Restricted stocks issued to employees are measured at the fair value of the equity instruments granted at the grant date, and are recognised as compensation cost over the vesting period.
-
(b) For restricted stocks where those stocks do not restrict distribution of dividends to employees and employees are not required to return the dividends received if they resign during the vesting period, the Company recognises the fair value of the dividends received by the employees who are expected to resign during the vesting period as compensation cost at the date of dividends declared.
-
~23~
- (c) Employees do not need to pay a price to obtain new shares with restricted employee rights. If the employee leaves the company within the vesting period, the company will take back the stock from the employee free of charge. On the grant date, the price to be paid will be estimated and recognized as remuneration in accordance with the terms and conditions of the issuance method Costs and Liabilities.
-
(24) Income tax
-
A. The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or items recognised directly in equity, in which cases the tax is recognised in other comprehensive income or equity.
-
B. The current income tax expense is calculated on the basis of the tax laws enacted or substantively enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in accordance with applicable tax regulations. It establishes provisions where appropriate based on the amounts expected to be paid to the tax authorities. An additional tax is levied on the unappropriated retained earnings and is recorded as income tax expense in the year the stockholders resolve to retain the earnings.
-
C. Deferred tax is recognised, using the balance sheet liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated balance sheet. However, the deferred tax is not accounted for if it arises from initial recognition of goodwill or of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred tax is provided on temporary differences arising on investments in subsidiaries and associates, except where the timing of the reversal of the temporary difference is controlled by the Company and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax is determined using tax rates (and laws) that have been enacted or substantially enacted by the balance sheet date and are expected to apply when the related deferred tax asset is realised or the deferred tax liability is settled.
-
D. Deferred tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised. At each balance sheet date, unrecognised and recognised deferred tax assets are reassessed.
~24~
-
E. Current income tax assets and liabilities are offset and the net amount reported in the balance sheet when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously. Deferred tax assets and liabilities are offset on the balance sheet when the entity has the legally enforceable right to offset current tax assets against current tax liabilities and they are levied by the same taxation authority on either the same entity or different entities that intend to settle on a net basis or realise the asset and settle the liability simultaneously.
-
F. A deferred tax asset shall be recognised for the carryforward of unused tax credits resulting from acquisitions of equipment or technology, research and development expenditures and equity investments to the extent that it is possible that future taxable profit will be available against which the unused tax credits can be utilised.
(25) Share capital
-
A. Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or stock options are shown in equity as a deduction, net of tax, from the proceeds.
-
B. Where the Company repurchases the Company’s equity share capital that has been issued, the consideration paid, including any directly attributable incremental costs (net of income taxes) is deducted from equity attributable to the Company’s equity holders. Where such shares are subsequently reissued, the difference between their book value and any consideration received, net of any directly attributable incremental transaction costs and the related income tax effects, is included in equity attributable to the Company’s equity holders.
(26) Dividends
Dividends are recorded in the Company’s financial statements in the period in which they are resolved by the Company’s shareholders. Cash dividends are recorded as liabilities.
-
(27) Revenue recognition
-
A. Sales of goods
-
(a) The Company manufactures and sells digital image technology application products. Sales are recognised when control of the products has transferred, being when the products are delivered to the buyer, the buyer has full discretion over the channel and price to sell the products, and there is no unfulfilled obligation that could affect the wholesaler’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the wholesaler, and either the wholesaler has accepted the products in accordance with the sales contract, or the Company has objective evidence that all criteria for acceptance have been satisfied.
-
(b) Revenue from these sales is recognised based on the price specified in the contract, net of the value-added tax, sales return, volume discounts, sales discounts and allowances.
-
(c) The Company’s obligation to provide a repair for faulty products under the standard warranty terms is recognised as a provision.
-
~25~
-
(d) A receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.
-
B. Technical service revenue
-
The Company provides technical support services. Revenue from providing services is recognised in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognised based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the number of delivered report relative to the total number of committed report.
5. Critical Accounting Judgements, Estimates and Key Sources of Assumption Uncertainty
The preparation of the parent company only financial statements requires management to make critical judgements in applying the Company’s accounting policies and make critical assumptions and estimates concerning future events. Assumptions and estimates may differ from the actual results and are continually evaluated and adjusted based on historical experience and other factors.
-
(a) Critical judgements in applying the Company’s accounting policies
-
None.
-
(b) Critical accounting estimates and assumptions
-
Evaluation of inventories
As inventories are stated at the lower of cost and net realisable value, the Company must determine the net realisable value of inventories on balance sheet date using judgements and estimates. Due to the rapid technology innovation, the Company evaluates the amounts of normal inventory consumption, obsolete inventories or inventories without market selling value on balance sheet date, and writes down the cost of inventories to the net realisable value. Therefore, there might be material changes to the evaluation.
As of December 31, 2022, the carrying amount of inventories was $237,720.
6. DETAILS OF SIGNIFICANT ACCOUNTS
(1) Cash and cash equivalents
| TAILS OF SIGNIFICANT ACCOUNTS Cash and cash equivalents |
||
|---|---|---|
| Cash on hand revolving funds Checking accounts and demand deposits Total |
December31,2022 346 $ 743,762 744,108 $ |
December31,2021 |
| 384 $ 684,287 |
||
| 684,671 $ |
-
A. The Company transacts with a variety of financial institutions all with high credit quality to disperse credit risk, so it expects that the probability of counterparty default is remote.
-
B. The Company has no cash and cash equivalents pledged to others.
~26~
(2) Financial assets at fair value through profit or loss
| Items Non-current items: Financial assets mandatorily measured at fair value through profit or loss Unlisted stocks Valuation adjustment Total |
December31,2022 10,312 $ 73,289 83,601 $ |
December31,2021 10,312 $ 68,872 79,184 $ |
|---|---|---|
- A. Amounts recognised in profit or loss in relation to financial assets at fair value through profit or loss are listed below:
| Equity instruments | For the year ended For the year ended December31,2022 December 31, 2021 4,417 $ 30,955 $ |
|---|---|
- B. The Company has no financial assets at fair value through profit or loss as at December 31, 2022 and 2021 pledged to others.
(3) Financial assets at fair value through other comprehensive income
| Items | December | 31,2022 | December | 31,2021 | ||
|---|---|---|---|---|---|---|
| Non-current items: | ||||||
| Equity instruments | ||||||
| Unlisted stocks | $ | 100,000 |
$ | 100,000 |
||
| Valuation adjustment | ( | 100,000) |
( | 100,000) |
||
| Total | $ | - |
$ | - |
-
A. The Company has elected to classify equity instruments that are considered to be strategic investments as financial assets at fair value through other comprehensive income. The fair value of such investments both amounted to $0 as at December 31, 2022 and 2021.
-
B. There were no amounts recognised in profit or loss and other comprehensive income in relation to the financial assets at fair value through other comprehensive income for the years ended December 31, 2022 and 2021.
-
C. The Company has no financial assets at fair value through profit or loss pledged to others as at December 31, 2022 and 2021.
(4) Accounts receivable
| December 31, 2022 and 2021. Accounts receivable |
||||||
|---|---|---|---|---|---|---|
| December | 31,2022 | December | 31, 2021 | |||
| Accounts receivable (including related parties) | $ | 1,173,158 |
$ | 917,414 |
||
| Less: Allowance for uncollectible accounts | ( | 234) |
( | 91) |
||
| $ | 1,172,924 | $ | 917,323 |
- A. The ageing analysis of accounts receivable and notes receivable that were past due but not impaired is as follows:
~27~
| Not past due Up to 30 days 31 to 90 days |
876,788 $ 267,861 28,509 1,173,158 $ December31,2022 |
December31,2021 |
|---|---|---|
| 897,788 $ 18,340 1,286 |
||
| 917,414 $ |
The above ageing analysis was based on past due date.
-
B. As at December 31, 2022 and 2021, accounts receivable were all from contracts with customers. And as of January 1, 2021, the balance of accounts receivable from contracts with customers amounted to $699,713.
-
C. None of the Company’s accounts receivable were pledged to others as collateral.
-
D. As at December 31, 2022 and 2021, without taking into account any collateral held or other credit enhancements, the maximum exposure to credit risk in respect of the amount that best represents the Company’s accounts receivable was $1,172,924 and $917,323, respectively.
-
E. Information relating to credit risk of accounts receivable is provided in Note 12(2).
-
(5) Inventories
| Inventories | |||
|---|---|---|---|
| Raw materials Work in progress Finished goods Total Raw materials Work in progress Finished goods Total |
Cost 17,985 $ 97,460 132,617 248,062 $ |
Allowance for valuation loss 4,038) ($ 4,275) ( 2,029) ( 10,342) ($ December31,2022 December 31, 2021 |
Bookvalue |
| 13,947 $ 93,185 130,588 |
|||
| 237,720 $ |
|||
| Cost 20,576 $ 70,801 77,761 169,138 $ |
Bookvalue | ||
| 17,837 $ 70,627 75,965 |
|||
| 164,429 $ |
The cost of inventories recognised as expense for the period:
| Cost of goods sold and others Loss in market value Total |
For the year ended December31,2022 8,793,027 $ 5,633 8,798,660 $ |
For the year ended December 31, 2021 |
|---|---|---|
| 4,633,305 $ 728 |
||
| 4,634,033 $ |
~28~
(6) Investments accounted for using equity method
| Investments accounted for using equity method | ||
|---|---|---|
| Altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co., Ltd. Altek Investment Corporation Altek Medical Holding(Cayman) Co., Ltd.(Note) |
December31,2022 8,255,923 $ 10,190 1,270,802 99,796 875,644 10,512,355 $ |
December31,2021 8,258,680 $ 10,101 1,061,246 99,872 - |
| 9,429,899 $ |
Note :These represents the purchase of Altek Medical Holding (Cayman) Co. , Ltd. equity from Altek International Holding (BVI) Co., Ltd. This transaction is an adjustment of the investment structure within the group.
-
A. For information on the Company’s subsidiary, please refer to Note 4(3) in the consolidated financial statements for the year ended December 31, 2022.
-
B. The Company recognised gain on investment in associates amounting to $498,538 and $410,665 for the years ended December 31, 2022 and 2021, respectively.
~29~
(7) Property, plant and equipment
| At January 1 Cost Accumulated depreciation Opening net book amount Additions Reclassifications Depreciation charge Closing net book amount At December 31 Cost Accumulated depreciation |
2022 | |||
|---|---|---|---|---|
~30~
2021
| At January 1 Cost Accumulated depreciation Opening net book amount Additions Depreciation charge Closing net book amount At December 31 Cost Accumulated depreciation |
Construction in progress and Buildings and to be inspected Land structures Machinery Test equipment equipment Others Total 468,684 $ 1,189,337 $ 626 $ 59,811 $ - $ 50,863 $ 1,769,321 $ - 358,716) ( 626) ( 56,604) ( - 48,172) ( 464,118) ( 468,684 $ 830,621 $ - $ 3,207 $ - $ 2,691 $ 1,305,203 $ 468,684 $ 830,621 $ - $ 3,207 $ - $ 2,691 $ 1,305,203 $ - 1,732 - 862 1,047 1,767 5,408 - 32,837) ( - 1,602) ( - 2,018) ( 36,457) ( 468,684 $ 799,516 $ - $ 2,467 $ 1,047 $ 2,440 $ 1,274,154 $ 468,684 $ 1,191,069 $ 626 $ 60,583 $ 1,047 $ 52,630 $ 1,774,639 $ - 391,553) ( 626) ( 58,116) ( - 50,190) ( 500,485) ( 468,684 $ 799,516 $ - $ 2,467 $ 1,047 $ 2,440 $ 1,274,154 $ |
|---|---|
A. For the years ended December 31, 2022 and 2021, there was no capitalisation of borrowing interests attributable to the property, plant and equipment.
B. Information about the property, plant and equipment that were pledged to others as collaterals is provided in Note 8.
~31~
- (8) Leasing arrangements lessee
-
A. The Company leases various assets including land, buildings and business vehicles. The term of the land lease contract is 20 years, the rest usually ranges from 1 to 3 years. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose covenants, but leased assets may not be used as security for borrowing purposes.
-
B. Short-term leases with a lease term of 12 months or less comprise buildings and equipment. Lowvalue assets comprise printers, etc.
-
C. The carrying amount of the depreciation charge are as follows:
| Land Buildings Transportation equipment (Business vehicles) Land Buildings Transportation equipment (Business vehicles) |
December31,2022 December31,2021 85,142 $ 87,943 $ 7,000 10,360 2,294 5,736 94,436 $ 104,039 $ Carryingamount Depreciationcharge |
December31,2022 December31,2021 85,142 $ 87,943 $ 7,000 10,360 2,294 5,736 94,436 $ 104,039 $ Carryingamount Depreciationcharge |
|---|---|---|
| For the year ended December 31, 2022 3,180 $ 3,360 3,442 9,982 $ |
For the year ended December31,2021 |
|
| 3,132 $ 3,080 4,981 |
||
| 11,193 $ |
-
D. For the years ended December 31, 2022 and 2021, the additions to right-of-use assets were $0 and $13,440, respectively.
-
E. The information on profit and loss accounts relating to lease contracts is as follows:
| Items affecting profit or loss Interest expense on lease liabilities Expense on short-term lease contracts Expense on leases of low-value assets |
For the year ended December31,2022 1,094 $ 3,294 211 |
For the year ended December31,2021 |
|---|---|---|
| 1,108 $ 3,281 102 |
-
F. For the years ended December 31, 2022 and 2021, the Company’s total cash outflow for leases were $14,095 and $15,216, respectively.
-
G. Extension and termination options
In determining the lease term, the Company takes into consideration all facts and circumstances that create an economic incentive to exercise an extension option. The assessment of lease period is reviewed if a significant event occurs which affects the assessment.
~32~
(9) Investment property
| At January 1 Cost Accumulated depreciation At January 1 Reclassifications Depreciation charge At December 31 At December 31 Cost Accumulated depreciation At January 1 Cost Accumulated depreciation At January 1 Depreciation charge At December 31 At December 31 Cost Accumulated depreciation |
Land Buildings and structures Total 573,532 $ 245,710 $ 819,242 $ - 69,145) ( 69,145) ( 573,532 $ 176,565 $ 750,097 $ 573,532 $ 176,565 $ 750,097 $ - 210) ( 210) ( - 6,817) ( 6,817) ( 573,532 $ 169,538 $ 743,070 $ 573,532 $ 245,411 $ 818,943 $ - 75,873) ( 75,873) ( 573,532 $ 169,538 $ 743,070 $ 2022 Land Buildings and structures Total 573,532 $ 245,710 $ 819,242 $ - 62,327) ( 62,327) ( 573,532 $ 183,383 $ 756,915 $ 573,532 $ 183,383 $ 756,915 $ - 6,818) ( 6,818) ( 573,532 $ 176,565 $ 750,097 $ 573,532 $ 245,710 $ 819,242 $ - 69,145) ( 69,145) ( 573,532 $ 176,565 $ 750,097 $ 2021 |
|---|---|
- A. Rental income from investment property and direct operating expenses arising from investment property are shown below:
For the year ended For the year ended December 31, 2022 December 31, 2021 Rental income from investment property $ 27,552 $ 27,552 Direct operating expenses arising from the investment property that generated rental income during the year $ 8,277 $ 8,240
~33~
-
B. The fair value of the investment property held by the Company as at December 31, 2022 and 2021 were both $1,051,328, which was valued by independent appraisers. Valuations were made using the comparative method and income approach to perform evaluation capitalization.
-
C. There was no capitalisation of borrowing interests attributable to investment property.
-
D. Information about the investment property that was pledged to others as collaterals is provided in Note 8.
(10) Intangible assets
| in Note 8. Intangible assets |
||||||||
|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | |||||||
| At January 1 | ||||||||
| Cost | $ | 11,127 |
$ | 14,141 |
||||
| Accumulated amortisation | ( | 6,983) |
( | 8,523) | ||||
| $ | 4,144 | $ | 5,618 | |||||
| At January 1 | $ | 4,144 |
$ | 5,618 |
||||
| Additions | 1,463 | 2,304 | ||||||
| Amortisation charge | ( | 2,843) |
( | 3,778) | ||||
| At December 31 | $ | 2,764 | $ | 4,144 | ||||
| At December 31 | ||||||||
| Cost | $ | 7,977 |
$ | 11,127 |
||||
| Accumulated amortisation | ( | 5,213) |
( | 6,983) | ||||
| $ | 2,764 |
$ | 4,144 | |||||
| A. Details of amortisation on intangible assets are as follows: | ||||||||
| For the year ended | For the year ended | |||||||
| December31,2022 | December31, | 2021 | ||||||
| Operating expense | 2,843 | 3,778 | ||||||
| B. The Company has no intangible assets pledged to others. | ||||||||
| Short-term borrowings | ||||||||
| Type of borrowings | December 31, 2022 | Interest rate range | Collateral | |||||
| Bank borrowings | ||||||||
| Unsecured borrowings | $ | 1,848,000 | 1.44%~2.09% | None | ||||
| Type of borrowings | December31,2021 | Interest rate range | Collateral | |||||
| Bank borrowings | ||||||||
| Unsecured borrowings | $ | 2,400,000 | 0.82%~0.89% | None |
- (11) Short-term borrowings
~34~
(12) Short-term notes and bills payable
| Short-term notes and bills payable | |||||
|---|---|---|---|---|---|
| December31,2022 | December31,2021 | ||||
| Commercial paper payable | $ | 400,000 |
600,000 $ |
||
| Less: Discount on short-term notes | |||||
| and bills payable | ( | 331) |
( | 182) |
|
| $ | 399,669 | 599,818 $ |
|||
| Interest rate ranges | 1.80%~1.90% | 0.84%~0.87% |
- (13) Long term borrowings
| Type of borrowings Borrowing period rate range Bank secured borrowings November 21, 2022 to November 21, 2023. 1.80% Less: Current portion |
Collateral December31,2022 Note 500,000 $ 500,000) ( - $ |
|---|---|
Note: The collateral of long-term borrowings, please refer to Note 8. At December, 31, 2021: None.
(14) Pensions
A. (a) The Company and its domestic subsidiaries have a defined benefit pension plan in accordance with the Labor Standards Act, covering all regular employees’ service years prior to the enforcement of the Labor Pension Act on July 1, 2005 and service years thereafter of employees who chose to continue to be subject to the pension mechanism under the Act. Under the defined benefit pension plan, two units are accrued for each year of service for the first 15 years and one unit for each additional year thereafter, subject to a maximum of 45 units. Pension benefits are based on the number of units accrued and the average monthly salaries and wages of the last 6 months prior to retirement. The Company contributes monthly an amount equal to 2% of the employees’ monthly salaries and wages to the retirement fund deposited with Bank of Taiwan, the trustee, under the name of the independent retirement fund committee.
(b) The amounts recognised in the balance sheet are as follows:
| December | 31,2022 | December | 31,2021 | |
|---|---|---|---|---|
| Present value of defined benefit obligations | ($ | 53,603) |
($ | 51,430) |
| Fair value of plan assets | 48,688 | 44,574 | ||
| Net defined benefit liability | ($ | 4,915) | ($ | 6,856) |
~35~
(c) Movements in net defined benefit liability are as follows:
| At January 1 Interest (expense) income Remeasurements: Return on plan assets (excluding amounts included in interest income or expense) Change in financial assumptions Experience adjustments Pension fund contribution Paid pension At December 31 At January 1 Interest (expense) income Remeasurements: Return on plan assets (excluding amounts included in interest income or expense) Change in demographic assumptions Change in financial assumptions Experience adjustments Pension fund contribution Paid pension At December 31 |
Present value of defined benefit obligations |
Fair value ofplan assets 2022 |
Net defined benefit liability 6,856) ($ 41) ( 6,897) ( 3,439 769) ( 2,464) ( 206 762 1,014 4,915) ($ |
|
|---|---|---|---|---|
| 51,430) ($ 308) ( 51,738) ( - 769) ( 2,464) ( 3,233) ( - 1,368 53,603) ($ |
44,574 $ 267 44,841 3,439 - - 3,439 762 354) ( 48,688 $ 2021 |
|||
| Present value of defined benefit obligations |
Fair value ofplanassets |
Net defined benefitliability |
||
| 54,843) ($ 165) ( 55,008) ( - 43) ( 1,481 1,315 2,753 - 825 51,430) ($ |
44,573 $ 134 44,707 680 - - - 680 12 825) ( 44,574 $ |
10,270) ($ 31) ( 10,301) ( 680 43) ( 1,481 1,315 3,433 12 - 6,856) ($ |
~36~
-
(d) The Bank of Taiwan was commissioned to manage the Fund of the Company’s and domestic subsidiaries’ defined benefit pension plan in accordance with the Fund’s annual investment and utilisation plan and the “Regulations for Revenues, Expenditures, Safeguard and Utilisation of the Labor Retirement Fund” (Article 6: The scope of utilisation for the Fund includes deposit in domestic or foreign financial institutions, investment in domestic or foreign listed, over-the-counter, or private placement equity securities, investment in domestic or foreign real estate securitization products, etc.). With regard to the utilisation of the Fund, its minimum earnings in the annual distributions on the final financial statements shall be no less than the earnings attainable from the amounts accrued from two-year time deposits with the interest rates offered by local banks. If the earnings is less than aforementioned rates, government shall make payment for the deficit after being authorized by the Regulator. The Company and domestic subsidiaries have no right to participate in managing and operating that fund and hence the Company and domestic subsidiaries are unable to disclose the classification of plan assets fair value in accordance with IAS 19 paragraph 142. The composition of fair value of plan assets as of December 31, 2022 and 2021 is given in the Annual Labor Retirement Fund Utilisation Report announced by the government.
-
(f) The principal actuarial assumptions used were as follows:
| Discount rate Future salary increases |
For the year ended December31,2022 1.30% 4.00% |
For the year ended December 31, 2021 |
|
|---|---|---|---|
| 0.60% 3.00% |
Assumptions regarding future mortality are set based on actuarial advice in accordance with published statistics and experience in Taiwan life insurance industry after 2022 and 2021. Because the main actuarial assumption changed, the present value of defined benefit obligation is affected. The analysis was as follows:
| obligation is affected. The | analysis was as follows: | analysis was as follows: | analysis was as follows: | analysis was as follows: | analysis was as follows: |
|---|---|---|---|---|---|
| December 31, 2022 Effect on present value of defined benefit obligations December 31, 2021 Effect on present value of defined benefit obligations |
Discount rate | ||||
| 1,121) ($ 1,156) ($ |
1,156 $ 1,194 $ |
1,002 $ 1,046 $ |
~37~
The sensitivity analysis above is based on one assumption which changed while the other conditions remain unchanged. In practice, more than one assumption may change all at once. The method of analysing sensitivity and the method of calculating net pension liability in the balance sheet are the same.
The methods and types of assumptions used in preparing the sensitivity analysis did not change compared to the previous period.
-
(g) Expected contributions to the defined benefit pension plans of the Company for the year ending December 31, 2023 amount to $972.
-
(h) As of December 31, 2022, the weighted average duration of the retirement plan is 9 years. The analysis of timing of the future pension payment was as follows:
| Within 1 year | $ | 6,745 |
|---|---|---|
| 2-5 years | 8,811 | |
| Over 5 years | 19,962 | |
| $ | 35,518 |
- B. Effective July 1, 2005, the Company has established a defined contribution pension plan (the “New Plan”) under the Labor Pension Act (the “Act”), covering all regular employees with R.O.C. nationality. Under the New Plan, the Company contributes monthly an amount based on 6% of the employees’ monthly salaries and wages to the employees’ individual pension accounts at the Bureau of Labor Insurance. The benefits accrued are paid monthly or in lump sum upon termination of employment. The pension costs under defined contribution pension plans of the Company for the years ended December 31, 2022 and 2021, were $ 15,960 and $14,750, respectively, under the above pension scheme.
~38~
(15) Share-based payment
- A. For the years ended December 31, 2022 and 2021, the Company’s share-based payment arrangements were as follows:
==> picture [457 x 64] intentionally omitted <==
----- Start of picture text -----
Quantity
granted
(shares in Contract Vesting
Type of arrangement Grant date thousand) period conditions
----- End of picture text -----
| Type ofarrangement | Grant date |
thousand) | period | conditions |
|---|---|---|---|---|
| Plan for restricted | January 20, 2020 | 2,196 | 3 years | Note 2 |
| shares to employees (2018-1) | ||||
| Plan for restricted | January 20, 2020 | 2,030 | 3 years | Note 2 |
| shares to employees (2019-1) | ||||
| " | April 24, 2020 | 86 | 3 years | Note 2 |
| Treasury shares transferred to | March 9, 2021 | 2,000 | - | Immediately |
| employees | vested | |||
| " | May 17, 2021 | 2,000 | - | Immediately |
| vested | ||||
| " | October 14, 2021 | 2,000 | - | Immediately |
| vested | ||||
| " | January 11, 2023 | 1,000 | - | Immediately |
| vested | ||||
| " | July 6, 2023 | 1,910 | - | Immediately |
| vested |
Note : The restricted shares were issued at no consideration to the Company’s existing employees whose service years have reached 1 year, 2 years and 3 years and who achieved the performance requirement. The vested ratio is 40%, 30% and 30%, respectively. If employees who are entitled to receive restricted stocks do not meet the vesting conditions, the Company will redeem at no consideration and retire those shares. The stocks and dividends distributed to employees during the vesting period shall be given by the Company at no consideration. Employees are not required to return the stocks and dividends if they resign during the vesting period.
-
B. Restricted shares to employees:
-
(a) The information on restricted shares to employees is as follows (share in thousands):
| For the year ended | For the year ended | |||
|---|---|---|---|---|
| December31,2022 | December31,2021 | |||
| Shares ungranted beginning balance | 2,679 | 4,968 | ||
| Shares exercised | ( | 1,384) |
( | 1,993) |
| Shares forfeited - retired | ( | 383) |
( | 296) |
| Shares ungranted ending balance | 912 | 2,679 |
~39~
-
(b) As of December 31, 2022, the Company collected 383 thousand shares of restricted shares because certain employees did not meet the vesting condition, and the change of registration has been completed.
-
C. As of December 31, 2022 and 2021, the weighted-average experience price of treasury shares transferred to employees was $18.24 (in NT dollars) and $19.66 (in NT dollars).
-
D. For information of fair value of the share-based payment transactions granted by the Company is as follows:
| is as follows: | ||||||||
|---|---|---|---|---|---|---|---|---|
| Type of arrangement | Grant date | Stock price (in NT dollars) |
Exercise price (Note) (in NT dollars) |
Expected price volatility |
Expected option life |
Expected dividends |
Risk-free interest rate |
Fair value per unit (in NT dollars) |
| Plan for restricted shares to employees (2018-1) Plan for restricted shares to employees (2019-1) " Treasury shares transferred to employees " " " " |
January 20, 2020 January 20, 2020 April 24, 2020 March 9, 2021 May 17, 2021 October 14, 2021 January 11, 2022 July 6, 2022 |
$22.80 22.80 18.20 34.10 27.95 31.90 43.50 31.25 |
$ - - - 21.08 18.24 ~21.08 18.24 18.24 18.24 |
NA NA NA NA NA NA NA NA |
3 years 3 years 3 years - - - - - |
NA NA NA NA NA NA NA NA |
NA NA NA NA NA NA NA NA |
$ 22.80 22.80 18.20 34.10 27.95 31.90 43.50 31.25 |
- E. Expenses incurred on share-based payment transactions are shown below:
| (16) | Provisions Equity-settled At January 1, 2022 Additional provisions Used during the period Reversed during the period At December 31, 2022 Current Non-current |
For the year ended For the year ended December31,2022 December 31, 2021 52,339 $ 85,976 $ Warranty 38,655 $ 24,033 838) ( 154) ( 61,696 $ December31,2022 December31,2021 32,346 $ 9,305 $ 29,350 $ 29,350 $ |
|---|---|---|
~40~
The Company gives warranties on digital image technology application products sold. Provision for warranty is estimated based on historical warranty data of digital image technology application products.
(17) Share capital
As of December 31, 2022, the Company’s authorized capital was $5,000,000, consisting of 500,000 thousand shares of ordinary stock, and the paid-in capital was $2,788,180 with a par value of $10 (in NT dollars) per share.
- A. Movements in the number of the Company’s ordinary shares outstanding are as follows (share in thousands):
| in thousands): | ||
|---|---|---|
| 2022 | 2021 | |
| At January 1 | 272,001 | 268,497 |
| Treasury shares transferred to employees | 5,110 | 3,800 |
| Retired restricted shares to employees that | ||
| did not meet the vesting conditions | 383) ( |
296) ( |
| At December 31 | 276,728 |
272,001 |
-
B. Treasury shares
-
(a) Reason for share reacquisition and the number of the Company’s treasury shares are as follows :
| Name of company holding the shares |
Reason for reacquisition | Number of shares (shareinthousands) Carrying amount 2,090 38,101 $ Number of shares (share in thousands) Carryingamount 7,200 131,461 $ December31,2021 December31,2022 |
December31,2022 | December31,2022 |
|---|---|---|---|---|
| Carrying amount | ||||
| The Company Name of company holdingthe shares |
To be reissued to employees Reason for reacquisition |
38,101 $ |
||
| Carryingamount | ||||
| The Company | To be reissued to employees | 131,461 $ |
-
(b) Pursuant to the R.O.C. Securities and Exchange Act, the number of shares bought back as treasury share should not exceed 10% of the number of the Company’s issued and outstanding shares and the amount bought back should not exceed the sum of retained earnings, paid-in capital in excess of par value and realised capital surplus.
-
(c) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should not be pledged as collateral and is not entitled to dividends before it is reissued.
-
(d) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should be reissued to the employees within five years from the reacquisition date and shares not reissued within the five-year period are to be retired.
~41~
(18) Capital surplus
Pursuant to the R.O.C. Company Act, capital surplus arising from paid-in capital in excess of par value on issuance of common stocks and donations can be used to cover accumulated deficit or to issue new stocks or cash to shareholders in proportion to their share ownership, provided that the Company has no accumulated deficit. Further, the R.O.C. Securities and Exchange Act requires that the amount of capital surplus to be capitalised mentioned above should not exceed 10% of the paidin capital each year. Capital surplus should not be used to cover accumulated deficit unless the legal reserve is insufficient.
| At January 1 Changes in ownership interests in subsidiaries Treasury stock transferred to employees Retirement of employee restricted shares Employee restricted share granted Retirement of employee restricted shares At December 31 At January 1 Changes in ownership interests in subsidiaries Issuance of restricted shares to employees Employee restricted share granted Retirement of employee restricted shares At December 31 |
Share Employee stock premium options 1,847,105 $ 49,102 $ - - - - 49,102 49,102) ( 17,866 - - - 1,914,073 $ - $ |
Difference between consideration and carrying amount of subsidiaries Changes in ownership interests in disposed subsidiaries 1,534 $ 388,907 $ 1,534) ( 388,907) ( - - - - - - - - - $ - $ 2022 2021 |
||
|---|---|---|---|---|
| Difference between consideration and carrying amount of subsidiaries Changes in ownership interests in disposed subsidiaries 1,534 $ 397,909 $ - 9,002) ( - - - - - - 1,534 $ 388,907 $ |
~42~
(19) Retained earnings
-
A. According to the Company’s Articles of Incorporation, the annual earnings, if any, shall first be used to pay all taxes and offset prior years’ operating losses and then 10% of the remaining amount shall be set aside as legal reserve. Special reserve shall be set aside in accordance with the rules. The remaining amount plus the unappropriated earnings of prior years were distributed in new shares, which were proposed by the Board of Directors and resolved at the shareholders’ meeting.
-
All or some of the dividends and bonus could, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, be distributed in the form of cash and reported at the shareholders’ meeting.
-
B. The amount of dividends appropriated is based on the Company’s current year’s net income and prior years’ retained earnings, taking into account the Company’s financial structure and future operating plans. The distribution ratio of cash dividends to stock dividends is based on the Company’s funding status, diluted earnings per share and other factors. According to the dividend policy adopted by the Board of Directors, cash dividends shall account for at least 20% of the total dividends distributed.
-
C. Except for covering accumulated deficit or issuing new stocks or cash to shareholders in proportion to their share ownership, the legal reserve shall not be used for any other purpose. The use of legal reserve for the issuance of stocks or cash to shareholders in proportion to their share ownership is permitted, provided that the balance of the reserve exceeds 25% of the Company’s paid-in capital.
-
D. (a) In accordance with the regulations, the Company shall set aside special reserve from the debit balance on other equity items at the balance sheet date before distributing earnings. When debit balance on other equity items is reversed subsequently, the reversed amount could be included in the distributable earnings.
-
(b) The amounts previously set aside by the Company as special reserve on initial application of IFRSs in accordance with Order No. Financial-Supervisory-Securities-Corporate1010012865, dated April 6, 2012, shall be reversed proportionately when the relevant assets are used, disposed of or reclassified subsequently. Such amounts are reversed upon disposal or reclassified if the assets are investment property of land, and reversed over the use period if the assets are investment property other than land.
~43~
- E. The appropriation of 2021 and 2020 earnings had been resolved at the stockholders’ meeting on June 17, 2022 and August 26, 2021, respectively. Details are summarized below:
| 2021 | 2021 | 2020 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|
| Dividends per share | Dividends per share | |||||||
| Amount | (inNTdollars) | Amount | (in NT dollars) | |||||
| Legal reserve | $ | 22,592 |
$ | 15,943 |
||||
| Special reserve | 123,276 | 59,231 |
||||||
| Cash dividends | 190,401 |
$ | 0.7 |
134,249 | $ | 0.5 |
||
| $ | 336,269 |
$ | 209,423 |
The appropriation of 2021 and 2020 earnings were the same as that approved by the Board of Directors on March 10, 2022 and March 25, 2021, respectively.
- F. The appropriation of 2022 earnings had been proposed by the Board of Directors on March 10, 2023. Details are summarized below:
| 2023. Details are summarized below: | |||||
|---|---|---|---|---|---|
| 2022 | |||||
| Dividends per share | |||||
| Amount | (in NT dollars) | ||||
| Legal reserve | $ | 43,676 |
|||
| Reversal of special reserve | ( | 259,420) |
|||
| Cash dividends | 276,728 | $ | 1 |
||
| $ | 60,984 |
For the aforementioned distribution of 2022 earnings, except for cash dividends which were resolved and proposed by the Board of Directors on March 10, 2023, others were pending for approval at the shareholders’ meeting.
(20) Other equity items
| approval at the shareholders’ meeting. Other equity items |
eting. | |
|---|---|---|
| Unrealised Foreign currency losses on Unearned translation valuation compensation Total At January 1 653,974) ($ 120,857) ($ 12,528) ($ 787,359) ($ Valuation adjustment - 27,284) ( - 27,284) ( Currency translation differences: -Subsidiaries 286,704 - - 286,704 Retirement of restricted shares to employees - - 8,748 8,748 Share-based payment transactions - - 3,084 3,084 At December 31 367,270) ($ 148,141) ($ 696) ($ 516,107) ($ 2022 |
2022 | |
| Total |
~44~
| 2021 | 2021 | |||||||
|---|---|---|---|---|---|---|---|---|
| Unrealised | ||||||||
| Foreign currency | losses on | Unearned | ||||||
| translation | valuation | compensation | Total | |||||
| At January 1 | ($ | 550,536) |
($ | 101,020) |
46,142) ($ |
($ | 697,698) |
|
| Valuation adjustment | - |
( | 21,409) |
- |
( | 21,409) |
||
| Valuation adjustment-changed to | - |
1,572 | - | 1,572 |
||||
| retained earnings | ||||||||
| Currency translation differences: | ||||||||
| -Subsidiaries | ( | 103,438) |
- |
- |
( | 103,438) |
||
| Retirement of restricted shares | ||||||||
| to employees | - |
- | 6,684 | 6,684 | ||||
| Share-based payment transactions | - | - | 26,930 | 26,930 | ||||
| At December 31 | ($ | 653,974) | ($ | 120,857) |
12,528) ($ |
($ | 787,359) |
| (21) | Operating revenue A. Disaggregation of revenue from contracts with customers For the year ended December 31, 2022 Revenue from contracts with customers 9,493,624 $ |
For the year ended December31,2021 |
|---|---|---|
| 5,105,488 $ |
||
The Company derives revenue from the transfer of goods and services over time and at a point in time in the following major geographical regions:
| For the year ended December31,2022 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total For the year ended December31,2021 Revenue from external customer contracts Timing of revenue recognition At a point in time |
Asia 7,307,750 $ 7,305,819 $ 1,931 7,307,750 $ Asia 3,457,477 $ 3,457,477 $ |
Europe 121,905 $ 121,249 $ 656 121,905 $ Europe 135,513 $ 135,513 $ |
America 1,930,125 $ 1,911,200 $ 18,925 1,930,125 $ America 1,400,440 $ 1,400,440 $ |
Oceania 1,867 $ 1,867 $ - 1,867 $ Oceania - $ - $ |
Taiwan 131,977 $ 56,501 $ 75,476 131,977 $ Taiwan 112,058 $ 112,058 $ |
Total 9,493,624 $ 9,396,636 $ 96,988 9,493,624 $ Total |
|
|---|---|---|---|---|---|---|---|
| 5,105,488 $ |
|||||||
| 5,105,488 $ |
~45~
B. Contract liabilities
The Group has recognised the following revenue-related contract liabilities:
| December | 31, 2022 | December | 31, 2021 | January1,2021 | ||
|---|---|---|---|---|---|---|
| Contract liabilities | $ | 68,815 |
$ | 2,483 |
$ | 981 |
C. Revenue recognised from performance obligations satisfied in previous periods
| Interest income Other income Year ended December 31,2022 Revenue recognised that was included in the contract liability balance at the beginning of 1,090 $ For the year ended December31,2022 Interest income from bank deposits 1,008 $ Other interest income 31 1,039 $ For the year ended December 31, 2022 Rent income 27,403 $ Dividend income 2,289 Other income - others 1,259 30,951 $ |
Year ended December 31, 2021 |
|---|---|
| 45 $ |
|
| For the year ended December31,2021 614 $ 47 661 $ For the year ended December31,2021 |
|
| 26,700 $ 1,526 1,262 |
|
| 29,488 $ |
(22) Interest income
(23) Other income
(24) Other gains and losses
| Other gains and losses | ||
|---|---|---|
| Finance costs Net gains on financial assets at fair value through profit or loss Net currency exchange gains Interest expense : Bank loan Lease liabilities Other |
For the year ended December31,2022 4,417 70,966 75,383 $ For the year ended December31,2022 30,419 $ 1,094 3,451 34,964 $ |
For the year ended December31,2021 |
| 30,955 5,273 |
||
| 36,228 $ |
||
| For the year ended December31,2021 |
||
| 21,583 $ 1,108 2,826 |
||
| 25,517 $ |
(25) Finance costs
~46~
(26) Expenses by nature
| Expenses by nature | |
|---|---|
| For the year ended December31,2022 Employee benefit expenses 583,329 $ Depreciation charges on property, plant and equipment 34,941 Depreciation charges on right-of-use assets 9,982 Depreciation charges on investment property 6,817 Amortisation charges on intangible assets 2,843 |
For the year ended December31,2021 |
| 501,447 $ 36,457 11,193 6,818 3,778 |
(27) Employee benefit expenses
| Wages and salaries Labour and health insurance fees Pension costs Other personnel expenses |
For the year ended For the year ended December31,2022 December 31, 2021 528,447 $ 453,465 $ 26,472 23,949 16,001 14,781 12,409 9,252 583,329 $ 501,447 $ |
|---|---|
-
A. According to the Articles of Incorporation of the Company, when distributing earnings, the Company shall distribute compensation to the employees and pay remuneration to the directors that account for 10% to 20% and no higher than 5%, respectively, of distributable profit of the current period. If a company has accumulated deficit, earnings should be channeled to cover losses. Employees’ compensation can be distributed in the form of shares or in cash. Employees of subsidiaries that the Company holds more than 50% shareholding are entitled to receive aforementioned stock or cash.
-
Abovementioned distributable profit of the current period refers to the pre-tax profit before deduction of employees’ compensation and directors’ remuneration. A company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, have the profit distributed as employees’ compensation and directors’ remuneration; and in addition thereto a report of such distribution shall be submitted to the shareholders’ meeting.
-
B. For the years ended December 31, 2022 and 2021, employees’ compensation was accrued at $89,798 and $44,429, respectively; directors’ remuneration was accrued at $29,933 and $5,924, respectively. The aforementioned amounts were calculated based on the Articles of Incorporation of the Company and recognised in salary expenses.
-
Employees’ compensation and directors’ and supervisors’ remuneration for 2021 amounting to $44,429 and $5,924, respectively, as resolved at the meeting of Board of Directors were in agreement with those amounts recognized in the 2021 financial statements.
-
Information about employees’ compensation and directors’ remuneration of the Company as resolved at the meeting of Board of Directors will be posted in the “Market Observation Post System” at the website of the Taiwan Stock Exchange.
~47~
(28) Income tax
A. Income tax expense
(a) Components of income tax expense:
| Income tax A. Income tax expense (a) Components of income tax expense: |
Income tax A. Income tax expense (a) Components of income tax expense: |
Income tax A. Income tax expense (a) Components of income tax expense: |
|---|---|---|
| (b) The income tax charged to other comprehensive income is as follows: B. Reconciliation between income tax expense and accounting profit: For the year ended For the year ended December31,2022 December31,2021 Current tax: Income tax arising from current year 2,396 $ - $ Prior year income tax underestimation - 547 Tax paid outside of the territory of the Republic of China - 30 Total current tax 2,396 577 Deferred tax: Origination and reversal of temporary differences 19,784 20,529 Income tax expense 22,180 $ 21,106 $ For the year ended For the year ended December 31, 2022 December 31, 2021 Changes in fair value of financial assets at fair value through other comprehensive income - $ 255 $ Translation differences of foreign 71,676 25,860) ( Benefit obligations revaluation 41 687 71,717 $ 24,918) ($ For the year ended December31,2022 For the year ended December31,2021 Tax calculated based on profit before tax and statutory tax rate 95,784 $ 49,168 $ Tax exempt income or expenses disallowed by tax regulation 1,237) ( 6,421) ( Prior year income tax underestimation - 547 Tax paid outside of the territory of the Republic of China - 30 Change in assessment of realisation of deferred tax assets 72,367) ( 22,218) ( Income tax expense 22,180 $ 21,106 $ |
||
| 95,784 $ 1,237) ( - - 72,367) ( 22,180 $ |
49,168 $ 6,421) ( 547 30 22,218) ( 21,106 $ |
~48~
- C. Amounts of deferred tax assets or liabilities as a result of temporary differences, tax losses and investment tax credits are as follows:
| Deferred tax assets: Temporary differences: Cost of after-sales service and other estimated expenses Currency translation differences Tax losses Investment tax credits Subtotal Deferred tax liabilities: Temporary differences: Gain on foreign investment under equity method Pension expense Others Subtotal Total Deferred tax assets: Temporary differences: Cost of after-sales service and other estimated expenses Currency translation differences Others Tax losses Investment tax credits Subtotal Deferred tax liabilities: Temporary differences: Gain on foreign investment under equity method Pension expense Others Subtotal Total |
January1 | Recognised in profit or loss Recognised in other comprehensive income December31 2,942 $ - $ 14,590 $ - 71,676) ( 62,327 11,046) ( - - 203) ( - 679 8,307) ($ 71,676) ($ 77,596 $ 8,710) ($ - $ 488,077) ($ 347) ( 41) ( 1,960) ( 2,420) ( - 4,299) ( 11,477) ($ 41) ($ 494,336) ($ 19,784) ($ 71,717) ($ 416,740) ($ 2022 2021 |
Recognised in profit or loss Recognised in other comprehensive income December31 2,942 $ - $ 14,590 $ - 71,676) ( 62,327 11,046) ( - - 203) ( - 679 8,307) ($ 71,676) ($ 77,596 $ 8,710) ($ - $ 488,077) ($ 347) ( 41) ( 1,960) ( 2,420) ( - 4,299) ( 11,477) ($ 41) ($ 494,336) ($ 19,784) ($ 71,717) ($ 416,740) ($ 2022 2021 |
|
|---|---|---|---|---|
| 11,648 $ 134,003 11,046 882 157,579 $ 479,367) ($ 1,572) ( 1,879) ( 482,818) ($ 325,239) ($ |
||||
| January1 | Recognised in other comprehensive income December31 - $ 11,648 $ 25,860 134,003 255) ( - - 11,046 - 882 25,605 $ 157,579 $ - $ 479,367) ($ 687) ( 1,572) ( - 1,879) ( 687) ($ 482,818) ($ 24,918 $ 325,239) ($ |
|||
| 22,619 $ 108,143 255 2,434 717 134,168 $ 461,253) ($ 889) ( 1,654) ( 463,796) ($ 329,628) ($ |
~49~
- D. Details of the amount the Company is entitled as investment tax credit and unrecognised deferred tax assets are as follows:
==> picture [456 x 137] intentionally omitted <==
----- Start of picture text -----
December 31, 2022
Unrecognised
Qualifying items Unused tax credits deferred tax assets Expiry year
Research and development $ 6,786 $ 6,107 2023
December 31, 2021
Unrecognised
Qualifying items Unused tax credits deferred tax assets Expiry year
Research and development $ 8,820 $ 7,938 2022
----- End of picture text -----
- E. Expiration dates of unused tax losses and amounts of unrecognised deferred tax assets are as follows:
December 31, 2022:None.
| Year incurred | Amount filed/ assessed |
Unused amount 17,466 $ 5,053 32,710 55,229 $ December 31,2021 |
Unused amount 17,466 $ 5,053 32,710 55,229 $ December 31,2021 |
Unused amount 17,466 $ 5,053 32,710 55,229 $ December 31,2021 |
Unrecognised deferred taxassets Expiry year - $ 2028 - 2030 - 2031 - $ |
|
|---|---|---|---|---|---|---|
| 2018 2020 2021 |
17,466 $ 5,053 32,710 55,229 $ |
17,466 $ 5,053 32,710 55,229 $ |
-
F. The amounts of deductible temporary difference that are not recognised as deferred tax assets are as follows: None.
-
G. The Company’s income tax returns through 2020 have been assessed and approved by the Tax Authority.
~50~
(29) Earnings per share
| Earnings per share | |||
|---|---|---|---|
| Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees Employees’ bonus Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees Treasury shares transferred to employees Employees’ bonus Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares |
Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in NT dollars) 456,742 $ 273,374 1.67 $ 456,742 $ - 1,194 - 2,921 456,742 $ 277,489 1.65 $ For theyear ended December 31,2022 For theyear ended December31,2021 |
||
| Amount after tax 224,734 $ 224,734 $ - - - 224,734 $ |
Weighted average number of ordinary shares outstanding (share in thousands) 265,654 2,719 1,203 1,135 270,711 |
Earnings per share (in NT dollars) |
|
| 0.85 $ |
|||
| 0.83 $ |
~51~
(30) Supplemental cash flow information
Investing activities with partial cash payments
| For the year ended | For the year ended | For the year ended | For the year ended | |||
|---|---|---|---|---|---|---|
| December31,2022 | December31,2021 | |||||
| Acquisition of property, plant, and | ||||||
| equipment | $ | 3,636 |
$ | 5,408 |
||
| Add: Property and equipment and | ||||||
| construction billings payable at | ||||||
| beginning of year | 208 |
4,203 | ||||
| Less: Property and equipment and | ||||||
| construction billings payable at end | ||||||
| of year | ( | 67) |
( | 208) |
||
| Cash paid | $ | 3,777 | $ | 9,403 | ||
| For the year ended | For the year ended | |||||
| December31,2022 | December31,2021 | |||||
| Acquisition of intangible assets | $ | 1,463 |
$ | 2,304 |
||
| Add: Payables at beginning of year | 206 | 278 | ||||
| Less: Payables at end of year | - | ( | 206) |
|||
| Cash paid | $ | 1,669 | $ | 2,376 |
(31) Changes in liabilities from financing activities
| January 1, 2022 Changes in cash flow from financing activities Interest expenses Changes in other non-cash items December 31, 2022 January 1, 2021 Changes in cash flow from financing activities Interest expenses Changes in other non-cash items December 31, 2021 |
Short-term borrowings |
Short-term borrowings |
Short-term notes and billspayable |
Short-term notes and billspayable |
Long-term borrowings (Note) |
Guarantee deposits received |
Lease liabilities |
Total | Total | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,400,000 $ 552,000) ( - - 1,848,000 $ Short-term borrowings |
599,818 $ 203,600) ( 3,451 - 399,669 $ Short-term notes and billspayable |
- $ 500,000 - - 500,000 $ Long-term borrowings (Note) |
6,445 $ - - - 6,445 $ Guarantee deposits received |
105,536 $ 10,590) ( 1,094 379 96,419 $ Lease liabilities |
3,111,799 $ 266,190) ( 4,545 379 2,850,533 $ Total |
||||||
| 2,330,000 $ 70,000 - - 2,400,000 $ |
299,798 $ 297,194 2,826 - 599,818 $ |
250,000 $ 250,000) ( - - - $ |
6,436 $ 9 - - 6,445 $ |
102,821 $ 11,833) ( 1,108 13,440 105,536 $ |
2,989,055 $ 105,370 3,934 13,440 3,111,799 $ |
Note: The loan will be due within one year, and it is listed as “long-term liabilities, current portion”.
~52~
7. RELATED PARTY TRANSACTIONS
| (1) | Names of related parties and relationship: Names of related parties |
Relationship withthe Company |
|---|---|---|
| Altek International Investment Co., Ltd.(AII) Altek International Trading Co., Ltd. (AIT) Altek Lab Inc.(ALI) Altek Semiconductor (Cayman) Co., Ltd.(Cayman) (ASMC) Altek Internatinoal Holding (BVI) Co., Ltd.(AIH) Altek Semiconductor Corporation (SEMI) Altek Biotechnology Corporation (BIO) Altek Medical Holding (Cayman) Co., Ltd. Taiwan Branch (AMH-TW) Altek Investment Corporation (AIC) Altek Medical (Kunshan) Limited(MED-KS) |
A subsidiary included in the Group's Consolidated Financial Statements (Note) " " " " " " " " " |
Note: For information on the Company’s subsidiary, please refer to Note 4(3) in the consolidated financial statements for the year ended December 31, 2022.
(2) Significant transactions and balances with related parties:
A. Operating revenue:
| Operating revenue: | ||||
|---|---|---|---|---|
| Sales of Goods: AIT SEMI BIO AMH-TW MED-KS Subtotal Sales of services: SEMI BIO Subtotal Total |
Year ended December 31, 2022 |
Year ended December 31, 2021 |
||
| 282 $ 1 20,887 32,657 3,076 56,903 31,941 $ 42,769 74,710 131,613 $ |
11 $ 12,010 1,759 2,017 - 15,797 38,619 $ 49,773 88,392 104,189 $ |
Goods are sold based on the prices lists in force and terms that would be available to third parties, and the general collection term was 45~90 days after monthly billings.
~53~
B. Purchases:
| Purchases: | ||||
|---|---|---|---|---|
| Year | ended December 31, | Year | ended December 31, | |
| 2022 | 2021 | |||
| Purchases of Goods: | ||||
| AIT | $ | 7,983,832 |
$ | 4,196,943 |
| Other | 8,878 |
792 |
||
| Total | $ | 7,992,710 | $ | 4,197,735 |
Goods are purchased on normal commercial terms and conditions, and the payment terms was 60~120 days after monthly billings.
C. Rent income:
| 60~120 days after monthly billings. Rent income: |
|||
|---|---|---|---|
SEMI BIO AMH-TW AIC Total |
Year ended December 31, 2022 |
Year ended December 31, 2021 |
|
| 8,710 $ 8,374 540 24 17,648 $ |
10,566 $ 5,192 540 24 16,322 $ |
D. Service fees:
| Service fees: | |||
|---|---|---|---|
| Receivables from related parties: SEMI BIO ALI Total Accounts receivable: SEMI BIO AMH-TW MED-KS Total SEMI BIO Other Total Other receivables: |
Year ended December 31, 2022 |
Year ended December 31, 2021 |
|
| 21,457 $ - 19,706 41,163 $ December31,2022 1 $ - - 736 737 $ 68,187 $ 15,399 243 83,829 $ |
10,385 $ 3,767 - 14,152 $ December31,2021 1,354 $ 556 794 - 2,704 $ 67,233 $ 20,678 260 88,171 $ |
E. Receivables from related parties:
~54~
F. Payables to related parties:
| Payables to related parties: | |
|---|---|
Loans from related parties-shown as other payables:December31,2022 Accounts payable: AIT 1,669,861 $ Other 71 Total 1,669,932 $ AIT 2,704 $ SEMI 17,632 ALI 6,150 Total 26,486 $ Other payables: December 31, 2022 AII 214,970 $ |
December31,2021 1,193,335 $ 6 |
| 1,193,341 $ |
|
| 8,980 $ 4,400 - |
|
| 13,380 $ |
|
| December 31, 2021 | |
| - $ |
- G. Loans from related parties shown as other payables:
AII
The loans from related-parties is repayable within 2 years, and the interest rate in 2022 was 0%.
H. Endorsements and guarantees provided to related parties:
December 31, 2022 December 31, 2021 - ASMC $ 153,550 $
I. Property transactions:
- (1) Disposal of property, plant and equipment:
For the year ended December 31, 2022 Disposal proceeds Gain (loss) on disposal BIO $ 384,000 $ -
The transaction price refers to the valuation report issued by a professional valuation agency. As of December 31, 2022, the transfer procedure of the transaction was in progress, and the amount the related party had paid was $345,600 (shown as other current liabilities) in accordance with the agreement.
For the year ended December 31, 2021: None.
- (2) Acquisition of financial assets:
For the year ended December 31, 2022
| For the year ended December31,2022 |
|||
|---|---|---|---|
| Trading partner |
Account items |
Number of shares traded Transactiontarget 45,063,084 Altek Medical Holding (Cayman) Co., Ltd. common Stock |
Get the price |
| AIH | Investments using the equity method |
755,272 $ |
For the year ended December 31, 2021: None.
~55~
(3) Key management compensation
| Key management compensation | |
|---|---|
| For the year ended December31,2022 Salaries and other short-term employee benefits 41,168 $ Post-employment benefits 998 Share-based payments 934 Total 43,100 $ |
For the year ended December31,2021 |
| 36,191 $ 1,027 5,927 43,145 $ |
8. PLEDGED ASSETS
The Company’s assets pledged as collateral are as follows:
| Pledged asset Purpose Land, buildings and structures Medium and long-term borrowings Investment property Medium and long-term borrowings |
Book value |
|---|---|
| December31,2022 December 31, 2021 212,743 $ - $ 736,980 - 949,723 $ - $ |
9. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNISED CONTRACT
COMMITMENTS
None.
10. SIGNIFICANT DISASTER LOSS
None.
11. SIGNIFICANT SUBSEQUENT EVENT
Earnings distribution plan of the Company for the year 2022 is provided in Note 6(19).
12. OTHERS
(1) Capital management
The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends, return capital or issue new shares to achieve the optimal capital structure.
~56~
(2) Financial instruments
A. Financial instruments by category
| nancial instruments Financial instruments by category |
||
|---|---|---|
| Financial assets Financial assets measured at fair value through profit or loss Financial assets at fair value through other comprehensive income Financial assets at amortised cost Cash and cash equivalents Accounts receivable (including related parties) Other receivables (including related parties) Guarantee deposit paid Financial liabilities Financial liabilities at amortised cost Short-term borrowings Short-term notes and bills payable Accounts payable (including related parties) Other payables (including related parties) Long-term borrowings (including current portion) Guarantee deposits received Lease liabilities |
December31,2022 83,601 $ - $ 744,108 $ 1,172,924 90,338 30,223 2,037,593 $ 1,848,000 $ 399,669 1,788,193 543,170 500,000 6,445 5,085,477 $ 96,419 $ |
December31,2021 |
| 79,184 $ |
||
| - $ |
||
| 684,671 $ 917,323 93,718 30,578 |
||
| 1,726,290 $ |
||
| 2,400,000 $ 599,818 1,230,319 223,866 - 6,445 |
||
| 4,460,448 $ |
||
| 105,536 $ |
B. Financial risk management policies
-
(a) The Company’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk and liquidity risk. To minimize any adverse effects on the financial performance of the Company, derivative financial instruments, such as foreign exchange forward contracts and foreign currency option contracts are used to hedge certain exchange rate risk, and interest rate swaps are used to fix variable future cash flows. Derivatives are used exclusively for hedging purposes and not as trading or speculative instruments.
-
(b) Risk management is carried out by a central treasury department (Company treasury) under policies approved by the Board of Directors. Company treasury identifies, evaluates and hedges financial risks in close co-operation with the Company’s operating units. The Board provides written principles for overall risk management, as well as written policies covering specific areas and matters, such as foreign exchange risk, interest rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments, and investment of excess liquidity.
~57~
-
C. Significant financial risks and degrees of financial risks
-
(a) Market risk
Foreign exchange risk
-
i. The Company operates internationally and is exposed to exchange rate risk arising from the transactions of the Company and its subsidiaries used in various functional currency, primarily with respect to the USD and RMB. Exchange rate risk arises from future commercial transactions and recognised assets and liabilities.
-
ii. Exchange rate risk arises when future commercial transactions, recognized assets or liabilities are denominated in a foreign currency that is not the entity's functional currency. The company's management has established a policy to hedge its overall exchange rate risk.
-
iii. The Company has certain investments in foreign operations, whose net assets are exposed to foreign currency translation risk. Currency exposure arising from the net assets of the Company’s foreign operations is managed primarily through borrowings denominated in the relevant foreign currencies.
-
iv. The information on assets and liabilities denominated in foreign currencies whose values would be materially affected by the exchange rate fluctuations is as follows:
December 31, 2022
| Foreign Currency Amount Exchange (In thousands) Rate (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 56,120 USD 30.710 Non-monetary items USD:NTD 338,704 USD 30.710 Financial liabilities Monetary items USD:NTD 66,238 USD 30.710 |
Book Value (NTD) 1,723,445 $ 10,402,369 $ 2,034,169 $ |
Effect on Effect on Other Extent of Profit or Comprehensive Variation (Loss) Income(Loss) 1% 17,234 $ - $ 1% - $ 104,024 $ 1% 20,342) ($ - $ SensitivityAnalysis |
|---|---|---|
~58~
December 31, 2021
| Foreign Currency Amount Exchange (In thousands) Rate (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 52,356 USD 27.680 RMB:NTD 539 RMB 4.3415 Non-monetary items USD:NTD 336,704 USD 27.680 Financial liabilities Monetary items USD:NTD 42,197 USD 27.680 RMB:NTD 1,273 RMB 4.3415 |
Effect on Effect on Other Book Value Extent of Profit or Comprehensive (NTD) Variation (Loss) Income(Loss) 1,449,214 $ 1% 14,492 $ - $ 2,340 1% 23 - 9,319,926 $ 1% - $ 93,199 $ 1,168,013 $ 1% 11,680) ($ - $ 5,527 1% 55) ( - SensitivityAnalysis |
|---|---|
- v. Total exchange gain including realised and unrealised arising from significant foreign exchange variation on the monetary items held by the Company for the years ended December 31, 2022 and 2021 amounted to $70,966 and $5,273, respectively.
Price risk
-
i. The Company’s equity securities, which are exposed to price risk, are the held financial assets at fair value through profit or loss and financial assets at fair value through other comprehensive income.
-
ii. The Company’s investments in equity securities comprise shares issued by the domestic companies. The prices of equity securities would change due to the change of the future value of investee companies. If the prices of these equity securities had increased/decreased by 10% with all other variables held constant, post-tax profit for the years ended December 31, 2022 and 2021 would have increased/decreased by $8, 360 and $7,918, respectively, as a result of gains/losses on equity securities classified as at fair value through profit or loss. Other components of equity would have increased/decreased by $0 and $0, respectively, as a result of other comprehensive income classified as equity investment at fair value through other comprehensive income.
Cash flow and fair value interest rate risk
The company's interest rate risk mainly comes from long-term and short-term loans. When the loan interest rate rises or falls by 0.25%, and all other factors remain unchanged, the net profit before tax in 2022 and 2021 will decrease or increase by $5,870 and $6,000, respectively. Mainly due to changes in interest expenses due to borrowings with floating rates.
~59~
(b) Credit risk
-
i. Credit risk refers to the risk of financial loss to the Company arising from default by the clients or counterparties of financial instruments on the contract obligations. The main factor is that counterparties could not repay in full the accounts receivable based on the agreed terms.
-
ii. The Company manages their credit risk taking into consideration the entire company’s concern. According to the Company’s credit policy, each local entity in the Company is responsible for managing and analysing the credit risk for each of their new clients before standard payment and delivery terms and conditions are offered. Internal risk control assesses the credit quality of the customers, taking into account their financial position, past experience and other factors. Individual risk limits are set based on internal or external ratings in accordance with limits set by the Board of Directors. The utilisation of credit limits is regularly monitored.
-
iii. The Company measured internal operating procedures, past experience of trading customers, and actual transaction status. If the contract payments were past due over 90 days based on the terms, there has been a significant increase in credit risk on that instrument since initial recognition. If the contract payments were past due over 360 days based on the term, the default has occurred.
-
iv. The following indicators are used to determine whether the credit impairment of debt instruments has occurred:
-
(i) It becomes probable that the issuer will enter bankruptcy or other financial reorganization due to their financial difficulties;
-
(ii) The disappearance of an active market for that financial asset because of financial difficulties;
-
(iii) Default or delinquency in interest or principal repayments;
-
(iv) Adverse changes in national or regional economic conditions that are expected to cause a default.
-
v. The Company classifies customers’ accounts receivable in accordance with customer types. The Company applies the simplified approach using loss provision matrix to estimate expected credit loss under the provision matrix basis.
-
vi. The Company wrote-off the financial assets, which cannot be reasonably expected to be recovered, after initiating recourse procedures. However, the Company will continue executing the recourse procedures to secure their rights.
-
vii. The Company used the forecastability to adjust historical and timely information to access the default possibility of accounts receivable (included related parties). As of December 31, 2022 and 2021, respectively, the provision matrix is as follows:
~60~
| Up to 90 days past due December 31, 2022 Expected loss rate 0.02% Total book value 1,173,158 $ Loss allowance 234 $ Up to 90 days past due December 31, 2021 Expected loss rate 0.01% Total book value 917,414 $ Loss allowance 91 $ |
91~180 days past due 15% - $ - $ 91~180 days past due 15% - $ - $ |
181 to 360 days past due 30% - $ - $ 181 to 360 days past due |
Upto361 days 100% - $ - $ Upto361 days |
Total 1,173,158 $ 234 $ Total |
|---|---|---|---|---|
| 30% - $ - $ |
100% - $ - $ |
917,414 $ 91 $ |
viii. Movements in relation to the Company applying the simplified approach to provide loss allowance for accounts receivable (included related parties) are as follows:
| At January 1 (Reversal of) impairment loss At December 31 |
2022 2021 91 $ 137 $ 143 46) ( 234 $ 91 $ |
|---|---|
(c) Liquidity risk
-
i. Cash flow forecasting is performed in the operating entities of the Company and aggregated by Company treasury. Company treasury monitors rolling forecasts of the Company’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities. Such forecasting takes into consideration the Company’s debt financing plans, and compliance with internal balance sheet ratio targets.
-
ii. Surplus cash held by the operating entities over and above the balance required for working capital management are transferred to the Company treasury. Company treasury invests surplus cash in interest bearing current accounts, time deposits and marketable securities, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient head-room as determined by the above-mentioned forecasts.
iii.The Company has following undrawn borrowing facilities:
| 0 Fixed rate: Expiring within one year Expiring beyond one year |
December31,2022 2,496,000 $ 500,000 2,996,000 $ |
December31,2021 |
|---|---|---|
| 1,144,000 $ - |
||
| 1,144,000 $ |
~61~
iv.The table below analyses the Company’s non-derivative financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet date to the contractual maturity date for non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows.
| December 31, 2022 | Less | than 1year | 1year | to 3 years | Over | 3 years |
|---|---|---|---|---|---|---|
| Non-derivative financial liabilities: | ||||||
| Short-term borrowings | $ | 1,848,000 |
$ | - |
$ | - |
| Short-term notes and bills payable | 399,669 | - |
- |
|||
| Accounts payable (including related parties) |
1,788,193 |
- | - |
|||
| Other payables (including related parties) |
543,170 |
- | - |
|||
| Lease liabilities | 9,443 |
11,217 | 91,236 | |||
| Long-term borrowings (including current portion) |
500,000 | - | - | |||
| Guarantee deposits received | - |
6,445 | - | |||
| December 31, 2021 | Less | than 1year | 1year | to 3 years | Over | 3 years |
| Non-derivative financial liabilities: | ||||||
| Short-term borrowings | $ | 2,400,000 |
$ | - |
$ | - |
| Short-term notes and bills payable | 599,818 | - |
- | |||
| Accounts payable (including related parties) |
1,230,319 | - | - | |||
| Other payables (including related parties) |
223,866 | - | - | |||
| Lease liabilities | 10,573 | 16,838 | 94,610 | |||
| Guarantee deposits received | - | 6,445 | - |
(3) Fair value estimation
-
A. The different levels that the inputs to valuation techniques are used to measure fair value of financial and non-financial instruments have been defined as follows:
-
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date. A market is regarded as active where a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
-
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
-
Level 3: Unobservable inputs for the asset or liability. The fair value of the Company’s investment in equity investment without active market and investment property are included in Level 3.
-
B. Fair value information of investment property at cost is provided in Note 6(9).
~62~
-
C. Financial instruments was not measured at fair value, including the carrying amounts of cash and cash equivalents, accounts receivable (included related parties), other receivables (included related parties), deposits paid, long-term borrowings, short-term borrowings, short-term notes and bills payable, accounts payable (included related parties), other payables (included related parties), long-term borrowings (including current portion), deposits received and lease liabilities are approximate to their fair values.
-
D. The related information of financial and non-financial instruments measured at fair value by level on the basis of the nature, characteristics and risks of the assets and liabilities are as follows:
-
(a) The related information of nature of the assets is as follows:
| December 31, 2022 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Financial assets at fair value through other comprehensive income Unlisted stocks December 31, 2021 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Financial assets at fair value through other comprehensive income Unlisted stocks |
Level 1 - $ - - $ Level 1 - $ - - $ |
Level 2 - $ - - $ Level 2 - $ - - $ |
Level3 83,601 $ - 83,601 $ Level3 79,184 $ - 79,184 $ |
Total |
|---|---|---|---|---|
| 83,601 $ - |
||||
| 83,601 $ |
||||
| Total | ||||
| 79,184 $ - |
||||
| 79,184 $ |
~63~
-
(b) The methods and assumptions the Company used to measure fair value are as follows:
- i. Except for financial instruments with active markets, the fair value of other financial instruments is measured by using valuation techniques. The fair value of financial instruments measured by using valuation techniques can be referred to current fair value of instruments with similar terms and characteristics in substance, discounted cash flow method or other valuation methods, including calculated by applying model using market information available at the consolidated balance sheet date.
-
ii. The output of valuation model is an estimated value and the valuation technique may not be able to capture all relevant factors of the Company’s financial and non-financial instruments. Therefore, the estimated value derived using valuation model is adjusted accordingly with additional inputs.
-
E. For the years ended December 31, 2022 and 2021, there was no transfer between Level 1 and Level 2.
-
F. The following chart is the movement of Level 3 for the years ended December 31, 2022 and 2021:
| At January 1 Gains recognised in profit or loss At December 31 |
79,184 $ 4,417 83,601 $ 2022 |
2021 |
|---|---|---|
| 48,229 $ 30,955 |
||
| 79,184 $ |
-
G. For the years ended December 31, 2022 and 2021, there was no transfer of Level 3.
-
H. Accounting Department segment is in charge of valuation procedures for fair value measurements being categorised within Level 3, which is to verify independent fair value of financial instruments. Such assessment is to ensure the valuation results are reasonable by applying independent information to make results close to current market conditions, confirming the resource of information is independent, reliable and in line with other resources and represented as the exercisable price, and frequently calibrating valuation model, performing back-testing, updating inputs used to the valuation model and making any other necessary adjustments to the fair value.
-
I. The following is the qualitative information of significant unobservable inputs and sensitivity analysis of changes in significant unobservable inputs to valuation model used in Level 3 fair value measurement:
~64~
| Financial assets at fair value through profit or loss Unlisted shares Financial assets at fair value through profit or loss Unlisted shares |
Fair value at December 31, 2022 |
Valuation technique |
Significant unobservableinput Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium Significant unobservableinput |
Relationship of inputs to fairvalue The higher the multiple and control premium, the higher the fair value Relationship of inputs to fairvalue |
|---|---|---|---|---|
| 83,601 $ Fair value at December 31, 2021 |
Market comparable companies Valuation technique |
|||
| 79,184 $ |
Market comparable companies |
Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium |
The higher the multiple and control premium, the higher the fair value |
-
’
-
(4) The impact of the COVID 19 pandemic to the Group s operation
-
As of December 31, 2011, the Company assessed that the COVID-19 epidemic had no significant impact on the overall operating activities, financing and financial statements.
13. SUPPLEMENTARY DISCLOSURES
(1) Significant transactions information
-
A. Loans to others: Please refer to table 1.
-
B. Provision of endorsements and guarantees to others: Please refer to table 2.
-
C. Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures): Please refer to table 3.
-
D. Acquisition or sale of the same security with the accumulated cost exceeding NT$300 million or 20% of the Company’s paid-in capital: Please refer to table 4.
~65~
-
E. Acquisition of real estate reaching NT$300 million or 20% of paid-in capital or more: Please refer to table 5.
-
F. Disposal of real estate reaching NT$300 million or 20% of paid-in capital or more: Please refer to table 6.
-
G. Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paidin capital or more: Please refer to table 7.
-
H. Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 8.
-
I. Trading in derivative financial instruments undertaken during the reporting periods: None.
-
J. Significant inter-company transactions during the reporting periods: Please refer to table 9.
(2) Information on investees
Names, locations and other information of investee companies (not including investees in Mainland China): Please refer to table 10.
(3) Information on investments in Mainland China
-
A. The related information of investments in Mainland China: Please refer to table 11.
-
B. Significant transactions, either directly or indirectly through a third area, with investee companies in the Mainland Area: Please refer to table 7 ~ table 9.
(4) Major shareholders information
Please refer to table 12.
14. SEGMENT INFORMATION
Not applicable.
~66~
ALTEK CORPORATION STATEMENT OF CASH AND CASH EQUIVALENTS DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars, except foreign currency in dollars)
| Item Cash Cash on hand-New Taiwan Dollar -Foreign currency USD 3,794.00 at exchange rate of 30.71 RMB 6,551.00 at exchange rate of 4.4094 JPY 4,262.00 at exchange rate of 0.2324 Bank deposits Demand deposits and checking account Foreign currency demand deposits USD 17,712,801.69 at exchange rate of 30.71 RMB 4,665.45 at exchange rate of 4.4094 JPY 1,093,007.00 at exchange rate of 0.2324 HKD 1,724.51 at exchange rate of 3.938 EUR 15,124.85 at exchange rate of 32.72 GBP 775.77 at exchange rate of 37.09 Description |
Amount | |
|---|---|---|
| 200 $ 116 29 1 346 198,997 543,960 20 254 7 495 29 743,762 744,108 $ |
~67~
ALTEK CORPORATION STATEMENT OF TRADE RECEIVABLES DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
| Client Name | Description | Amount | Note | ||
|---|---|---|---|---|---|
| Customer: | |||||
| A | $ | 589,484 |
|||
| B | 269,321 | ||||
| C | 222,716 | ||||
| The balance of each | |||||
| customer has not | |||||
| exceeded 5% of the | |||||
| Other | 90,900 | accounts receivable | |||
| Subtotal | 1,172,421 | ||||
| Related parties : | |||||
| Altek Semiconductor Corporation | $ | 1 |
|||
| Altek Medical (Kunshan) Limited. | 736 | ||||
| Subtotal | 737 | ||||
| Total | 1,173,158 | ||||
| Less : Allowance for uncollectible accounts | ( | 234) |
|||
| $ | 1,172,924 |
~68~
ALTEK CORPORATION STATEMENT OF INVENTORIES
DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
==> picture [506 x 186] intentionally omitted <==
----- Start of picture text -----
Amount
Item Description Cost Net Realisable Value Note
Raw material $ 17,985 $ 14,781 Net realisable values
are used as market price
Work in progress 97,460 129,851 ''
''
Finished goods 132,617 156,304
248,062 $ 300,936
Less : Allowance for valuation loss ( 10,342)
$ 237,720
----- End of picture text -----
~69~
ALTEK CORPORATION
STATEMENT OF CHANGES IN FINANCIAL ASSETS MEASURED AT FAIR VALUE THROUGH PROFIT OR LOSS - NON-CURRENT FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
==> picture [748 x 138] intentionally omitted <==
----- Start of picture text -----
Beginning Balance Addition Ending Balance
Name of Financial Percentage
Instrument Shares Book Value Shares Amount Shares share holding Book Value Collateral Note
Gianta Co., Ltd. 762,876 $ 79,184 - $ 4,417 762,876 14.55% $ 83,601 None Note
Hua-chuang Automobile ''
Information Technical
Center Co.,Ltd. 2 - - - 2 0.00% -
$ 79,184 $ 4,417 $ 83,601
----- End of picture text -----
Note :Recognise valuation profit.
~70~
ALTEK CORPORATION
STATEMENT OF CHANGES IN INVESTMENTS ACCOUNTED FOR USING THE EQUITY METHOD FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
| Name | BeginningBalance | BeginningBalance | Shares Amount - - $ - 89 Note 2 - 209,556 Note 2 - - 45,063,684 875,644 Note 4 1,085,289 $ Addition |
Shares Amount - 2,757) ($ Note 1 - - - - - 76) ( Note 3 - - 2,833) ($ Decrease |
EndingBalance | EndingBalance | EndingBalance | Market Value or Net Assets Value |
Market Value or Net Assets Value |
Collateral |
|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Shares | Shares | Percentage of Ownership |
Amount | Unit Price |
Total Amount | ||
| Altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co., Ltd. Altek Investment Corporation Altek Medical Holding(Cayman) Co., Ltd. |
87,769,559 1,000 12,865,921 10,000,000 - |
8,258,680 $ 10,101 1,061,246 99,872 - 9,429,899 $ |
- - - - 45,063,684 |
- - - - - |
87,769,559 1,000 12,865,921 10,000,000 45,063,684 |
100% 100% 100% 100% 77.70% |
8,255,923 $ 10,190 1,270,802 99,796 875,644 10,512,355 $ |
- $ - - - - |
8,255,923 $ 10,190 1,270,802 99,796 875,644 10,512,355 $ |
None " " " " |
Note 1 :Including the repatriation of earnings, investment gains and losses recognised under the equity method, changes in cumulative conversion adjustments,
and the elimination of unrealised gains and losses adjustments for countercurrent transactions between companies, etc.
Note 2 :Including changes in investment gains and losses recognized under the equity method and cumulative conversion adjustments. Note 3 :Newly established investment funds and investment losses recognized under the equity method. Note 4 :It includes changes in the purchase price of equity, investment gains and losses recognised under the equity method and accumulated translation adjustments.
~71~
ALTEK CORPORATION STATEMENT OF TRADE PAYABLES
DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
==> picture [494 x 243] intentionally omitted <==
----- Start of picture text -----
Client Name Description Amount Note
Non related parties :
AA supplier $ 30,193
AB supplier 3,933
AC supplier 2,780
The balance of each
payable account has
not exceeded 5% of
Other 81,355
the accounts payable
Subtotal 118,261
Related parties :
Altek International Trading Co., Ltd. $ 1,669,861
Altek Biotechnology Corporation 71
Subtotal 1,669,932
Total $ 1,788,193
----- End of picture text -----
~72~
ALTEK CORPORATION STATEMENT OF SHORT, MEDIUM AND LONG-TERM BORROWINGS DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
==> picture [693 x 77] intentionally omitted <==
Note : The Company's land and buildings on the 1st to 7th floors of Tiding Building in Taipei and its affiliated parking spaces.
~73~
ALTEK CORPORATION STATEMENT OF OPERATING REVENUE FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
| Item | Volume Amount Note |
|---|---|
| Net operating revenue : | |
| Digital imaging related | |
| application products, etc. | 9,493,624 $ |
~74~
ALTEK CORPORATION STATEMENT OF OPERATING COSTS FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
==> picture [490 x 414] intentionally omitted <==
----- Start of picture text -----
Item Amount
Direct raw materials used
Raw materials at beginning of year $ 20,576
Add: Raw materials purchased 765,634
Less: Sale of raw materials ( 655,530)
Expenses transferred in ( 217)
Raw material deficit ( 13)
Raw materials at end of year ( 17,985)
Consumption of raw materials for the year 112,465
Manufacturing expenses 65,695
Manufacturing cost 178,160
Work in progress at beginning of year 70,801
Add: Work in progress purchased 1,658,727
Less: Expenses transferred in ( 3,806)
Sales of work in process ( 37,108)
Work in progress at end of year ( 97,460)
Cost of finished goods 1,769,314
Finished goods at beginning at the year 77,761
Add: Finished good purchased 6,287,793
Less: Expenses transferred in ( 5,613)
Finished goods at end of year ( 132,617)
Total cost of goods sold 7,996,638
Sales of raw materials and work in progress 692,638
Allowance of loss on decline in market 5,633
Raw material deficit 13
Other operating costs 103,738
Total operating cost $ 8,798,660
----- End of picture text -----
~75~
ALTEK CORPORATION STATEMENT OF MANUFACTURING COSTS FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
Item Description Amount Note Wages and salaries $ 42,732 Import and export expenses 6,996 Depreciation expense 3,565 The amount of each item in others does not exceed 5% of Other 12,402 the account balance $ 65,695
~76~
ALTEK CORPORATION STATEMENT OF SELLING EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
Item Description Amount Note Wages and salaries $ 17,541 Science Park management fees 3,915 The amount of each item in others does not exceed 5% of the Other 8,867 account balance $ 30,323
~77~
ALTEK CORPORATION STATEMENT OF ADMINISTRATIVE EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
==> picture [506 x 156] intentionally omitted <==
----- Start of picture text -----
Item Description Amount Note
Wages and salaries $ 159,914
Directors' remuneration 34,953
Depreciation charges 21,372
The amount of each item
in others does not exceed
5% of the account
Other 87,154 balance
$ 303,393
----- End of picture text -----
~78~
ALTEK CORPORATION STATEMENT OF RESEARCH AND DESIGN FOR THE YEAR ENDED DECEMBER 31, 2022
(Expressed in thousands of New Taiwan dollars)
Item Description Amount Note Wages and salaries $ 273,307 Service expenses 48,137 The amount of each item in others does not exceed 5% of the account balance Other 131,686 $ 453,130
~79~
ALTEK CORPORATION
SUMMARY STATEMENT OF CURRENT PERIOD EMPLOYEE BENEFITS, DEPRECIATION, DEPLETION AND AMORTIZATION EXPENSES BY FUNCTION
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
(Expressed in thousands of New Taiwan dollars)
| Nature Function |
Year ended December 31,2022 | Year ended December 31,2022 | Year ended December 31,2022 | Year ended December 31,2021 | Year ended December 31,2021 | Year ended December 31,2021 |
|---|---|---|---|---|---|---|
| Classified as Operating Costs |
Classified as Operating Expenses |
Total | Classified as Operating Costs |
Classified as Operating Expenses |
Total | |
| Employee benefit expense | 47,949 $ |
535,380 $ |
583,329 $ |
30,375 $ |
471,072 $ |
501,447 $ |
| Wages and salaries | 42,732 | 450,762 | 493,494 | 27,305 | 415,591 | 442,896 |
| Labor and health insurance fees | 2,673 | 23,799 | 26,472 | 1,590 | 22,359 | 23,949 |
| Pension costs | 1,251 | 14,750 | 16,001 | 764 | 14,017 | 14,781 |
| Directors' remuneration | - | 34,953 | 34,953 | - | 10,569 | 10,569 |
| Other personnel expenses | 1,293 | 11,116 | 12,409 | 716 | 8,536 | 9,252 |
| Depreciation charges | 3,565 | 48,175 | 51,740 | 2,040 | 52,428 | 54,468 |
| Amortisation charges | - | 2,843 | 2,843 | - | 3,778 | 3,778 |
Note:
-
As at December 31, 2022 and 2021, the Company had both 273 and 242 employees,including both 4 non-employee directors.
-
Average employee benefit expense in current year and previous year is $2,039 and $2,063, respectively. (Total employee benefits- directors' remuneration / number of employees - number of non-emplyee directors )
-
Average employees salaries in current year and previous year is $1,835 and $1,861, respectively. (Total employee salaries / number of employees - number of non-emplyee directors )
-
Adjustments of average employees salaries 1.4%. (Average employee salaries current year - Average employee salaries previous year / Average employee salaries previous year )
-
The supervisors’ remuneration for the years ended December 31, 2022 and 2021 were both $0, due to the establishment of the audit committee.
-
The Company’s policies of salary and remuneration were as follows:
The Company’s compensation for directors including directors’ return, traveling expenses and directors’ remuneration. In accordance with the Company’s Articles of Incorporation, directors’ return
was based on the degree of participant in the operation, value of contribution to the Company and common standard of the industry. Traveling expenses were based on the common standard of
the industry and the attendance of the Board of Directors. Directors’remuneration shall not be higher than 2% of the profit of current year.
The Company's compensation for managers and employees including salary, award and employees’ return were based on the contribution, experience, management performance and responsibility and referred to the standard of the same industry. Managers’ performance examination and salary and remuneration have been reviewed by the remuneration committee and the Board of Directors, and will be checked based on the actual management result and related laws accordingly. Additionally, in accordance with the Company’s Articles of Incorporation, employees’compensation shall be distributed based on 10% to 20% of the profit of the current year.
~80~
Table 1
Altek Corporation Loans to other For the year ended December 31, 2022
Expressed in thousands of NTD (Except as otherwise indicated)
| No. | Creditor | Borrower | General ledger account |
Is a related party |
Maximum outstanding balance during the year December 31, 2022 |
Balance at December 31, 2022 |
Actual amount drawn down |
Interest rate |
Nature of loan |
Amount of transactions with the borrower |
Reason term financing |
Allowance for doubtful accounts |
Collateral | Collateral | Limit on loans granted to a single party (Note) |
Ceiling on total loans granted (Note) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Item | Value | |||||||||||||||
| 0 1 2 3 |
Altek Corporation Altek Semiconductor (Cayman) Co.,Ltd. Altek (Kunshan) Co., Ltd. Altek International Investment Co., Ltd. |
Altek Semiconductor Corporation Altek Semiconductor Corporation Altek Optical Technology (Kunshan) Co. , Ltd. Altek Corporation |
Other receivables- related party Other receivables- related party Other receivables- related party Other receivables- related party |
Yes Yes Yes Yes |
400,000 $ 161,075 110,235 630,156 |
400,000 $ - 44,094 626,484 |
- $ - 44,094 214,970 |
1.5% 0% 3.2% 0% |
Reason for short-term financing Reason for short-term financing Reason for short-term financing Reason for short-term financing |
- $ - - - |
Operational need Operational need Operational need Operational need |
- $ - - - |
N/A N/A N/A |
- $ - - - |
894,682 $ 1,231,526 959,678 8,269,548 |
3,578,727 $ 1,231,526 1,919,355 8,269,548 |
Note 1: Where the amount of New Taiwan dollars in this attached table involves foreign currencies, it shall be converted into New Taiwan dollars at the exchange rate on the end date of the financial reporting period. Note 2: The ”Procedure for Provision of Loans” policy for loans granted by Altek Corporation is as follows: the ceiling on total loans is 40% of the net assets value of lender. For one company, the ceiling on loans is 10% of the net assets value of lender.
Note 3: The ”Procedure for Provision of Loans” policy for loans granted by Altek Semiconductor (Cayman) Co.,Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender. Note 4: The ”Procedure for Provision of Loans” policy for loans granted by Altek (Kunshan) Co., Ltd. is as follows: the ceiling on total loans is 40% of the net assets value of lender. For one company, the ceiling on loans is 20% of the net assets value of lender.
Note 5: The ”Procedure for Provision of Loans” policy for loans granted by Altek International Investment Co., Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender.
Table 1
Table 2
Expressed in thousands of NTD (Except as otherwise indicated)
Altek Corporation
Provision of endorsements and guarantees to others
For the year ended December 31, 2022
| Number | endorsed/guaranteed Party being |
endorsed/guaranteed Party being |
Relationship with the endorser/ guarantor |
Limited on endorsements/ guarantees provided for a singleparty |
Amount as at December 31, 2022 |
Guarantee amount at December 31, 2022 |
Actual amount drawn down |
Amount of endorsements/ gurantees secured with collateral |
Ratio of accumulated endorsement/ guarantee amount to net asset value of the endorser/ guarantor company |
Ceiling on total amount of endorsements/ guaranteesprovided |
Provision of endorsements/ guarantees by parent company to subsidiary |
Provision of endorsements/ guarantees by subsidiary to parent company |
Provision of endorsements/ guarantees to the party in Mainland China |
Footnote |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endorser/guarantor | Companyname | |||||||||||||
| 0 | Altek Corporation | Altek Semiconductor (Cayman) Co., Ltd. |
Note 2 | 1,789,364 $ |
154,450 $ |
153,550 $ |
- $ |
- $ |
1.73 | 4,473,409 $ |
Y | N | N |
Note 1: If the amount of NTD in this Note relates to foreign currencies, it is converted to NTD at the exchange rate at the end of the financial reporting period. Note 2: A company in which the company directly or indirectly holds more than 50% of the voting shares.
Note 3: According to the "Endorsement Guarantee Operation Procedures" of Altek Corporation the overall endorsement guarantee amount shall not exceed 50% of its net value,
and the endorsement guarantee amount of a single enterprise shall not exceed 20% of its net value.
Table 2
Altek Corporation
Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures)
December 31, 2022
| December 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|
| Table 3 Securities held by |
Marketable securities | Relationship with the securities issuer |
General ledger account |
As of December31,2022 Expressed in thousands of NTD (Except as otherwise indicated) |
|||
| Number of shares | Bookvalue | Ownership (%) | Fairvalue | ||||
| Altek Corporation " Altek (Kunshan) Co., Ltd. Altek EMS (Kunshan) Co., Ltd. |
Gianta Co., Ltd. - Common stock Hua-chuang Automobile Information Technical Center Co., Ltd. - Common stock CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership) Aimore Acoustivs Incorporation |
Director None None Director |
Financial assets at fair value through profit or loss - non-current Financial assets measured at fair value through other comprehensive income - non-current " " |
762,876 2 N/A N/A |
83,601 $ - 37,193 37,745 |
14.55% 0.00% (Note 1) (Note 2) |
83,601 $ - 37,193 37,745 |
Note 1: 1% of CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership)’s capital contribution. Note 2: 12.5% of Aimore Acoustivs Incorporation’s capital contribution.
Table 3
Altek Corporation
Accumulative purchase or sale of the same securities amounted to NT$300 million or more than 20% of the paid-in capital
For the year ended December 31, 2022 Table 4
| Buying and selling company Table 4 |
Marketable securities type and name |
Account subject |
Trading partners | Relation | Beginning | Beginning | Buy | Buy | Sell | Sell | Expressed in thousands of NTD (Except as otherwise indicated) Ending |
Expressed in thousands of NTD (Except as otherwise indicated) Ending |
Expressed in thousands of NTD (Except as otherwise indicated) Ending |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of shares |
Amount of money |
Number of shares |
Amount of money |
Number of shares |
Selling price | Book cost | Disposal profit and loss |
Number of shares |
Amount of money |
|||||
| Altek Corporation |
Altek Medical Holding (Cayman) Co., Ltd. Common stock |
Investments using the equity method |
Altek International Holding (BVI) Co., Ltd. |
Subsidiaries of the Company |
- | $ - | 45,063,684 | $ 755,272 | - | $ - | $ - | $ - | 45,063,684 | $ 875,644 |
Table 4
Table 5
Expressed in thousands of NTD
Altek Corporation
The amount of real estate acquired is NT$300 million or more than 20% of the paid-in capital
For the year ended December 31, 2022
(Except as otherwise indicated)
If the transaction object is a related party,
| Company that acquiresrealestate |
Propertyname | Date of fact | Amount of the transaction |
Payment situation | Trading partners | Relation | the previous data transfer | the previous data transfer | Reference basis for price determination |
Acquisition purpose and usage |
Other agreed matters |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Everyone | Relationship with Issuer |
Transfer date | Amount of money |
||||||||||
| Altek Biotechnology Corporation |
Land and Buildings in Neihu District, Taipei City |
August, 2022 | $ 384,000 | As of December 31, 2022, $345,600 has been paid in accordance with the contract |
Altek Corporation | Parent-subsidiary | Natural party | Non-related party |
December, 2010 | $ 314,084 | Refer to the valuation report issued by a professional valuation agency |
Group overall operation planning |
None |
Table 5
Altek Corporation
The amount of disposal of real estate amounted to NT$300 million or more than 20% of the paid-in capital
For the year ended December 31, 2022
Table 6
Expressed in thousands of NTD (Except as otherwise indicated)
| Companies disposing of real estate |
Propertyname | Date of fact | Original date of acquisition |
Book amount | Amount of the transaction |
Price Collection Situation | Disposal profit and loss |
Trading partners | Relation | Punishment purpose |
Reference basis for price determination |
Other agreed matters |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altek Corporation | Land and Buildings in Neihu District, Taipei City |
August, 2022 | December, 2010 | Note | 384,000 $ |
As of December 31, 2022, $345,600 has been received according to the contract |
Note | Altek Biotechnology Corporation |
Parent-subsidiary | Group overall operation planning |
Refer to the valuation report issued by a professional appraisal agency |
None |
Note: As of December 31, 2022, the transfer procedure of the transaction was in progress.
Table 6
Altek Corporation
Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more
For the year ended December 31, 2022
Table 7
Expressed in thousands of NTD (Except as otherwise indicated)
| Purchaser/seller | Counterparty | Relationship with the counterparty |
Transaction | Transaction | Differences in transaction terms compared to third party transactions |
Differences in transaction terms compared to third party transactions |
Notes/accounts receivable(payable) |
Notes/accounts receivable(payable) |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Purchases (sales) |
Amount | Percentage of total purchases (sales) |
Credit term | Unitprice | Credit term | Balance | Percentage of total notes/accounts receivable(payable) |
|||
| Altek Corporation Altek International Trading Co., Ltd. Altek Biotechnology Corporation Altek Medical Holding (Cayman) Co., Ltd. Taiwan Branch Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited |
Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited " Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. |
Parent-subsidiary The same ultimate parent company The same parent company The same parent company The same ultimate parent company The same ultimate parent company |
Purchases Purchases Purchases Purchases Purchases Purchases |
7,983,832 $ 8,691,718 2,042,670 503,597 721,726 488,200 |
92% 100% 99% 90% 8% 19% |
Net 120 days Net 75 days " " " " |
Approximately the same price with third parties " " " " " |
Note " " " " " |
1,669,861) ($ 1,424,318) ( 329,872) ( 109,292) ( - 348,514) ( |
93% 99% 99% 92% 0% 50% |
Note: The payment term with third parties was net 60~120 days.
Table 7
Altek Corporation
Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more
December 31, 2022
Table 8
Expressed in thousands of NTD (Except as otherwise indicated)
| Creditor | Counterparty | Relationship withthe counterparty |
Balance as atDecember31,2022 | Turnover rate | Overduereceivables | Overduereceivables | Amount collected subsequent to the balance sheet date |
Allowance for doubtfulaccounts |
Note |
|---|---|---|---|---|---|---|---|---|---|
| Amount | Actiontaken | ||||||||
| Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. " Altek Medical (Kunshan) Limited " Altek International Investment Co., Ltd. |
Altek Corporation Altek International Trading Co., Ltd. Altek Medical (Kunshan) Limited Altek Biotechnology Corporation Altek Medical Holding (Cayman) Co., Ltd. Taiwan Branch Altek Corporation |
Parent-subsidiary The same ultimate parent company The same ultimate parent company The same parent company The same parent company Parent-subsidiary |
1,669,861 $ 1,424,318 348,514 329,872 109,292 214,970 |
5.36 5.84 6.66 5.26 5.02 - |
- $ - - - - - |
N/A N/A N/A N/A N/A N/A |
1,416,751 $ 1,395,331 184,467 269,023 26,302 - |
- $ - - - - - |
Note |
Note: It is a loan to related party, shown as other receivables.
Table 8
Altek Corporation
Significant inter-company transactions during the reporting periods
For the year ended December 31, 2022
Table 9
Expressed in thousands of NTD
(Except as otherwise indicated)
| Companyname | Counterparty | Relationship (Note1) |
Transaction | |||
|---|---|---|---|---|---|---|
| General ledgeraccount | Amount | Transactionterms | Percentage of consolidated total operating revenues ortotalassets (Note2) |
|||
| Altek Corporation " Altek International Trading Co., Ltd. " Altek Biotechnology Corporation " Altek Medical Holding (Cayman) Co., Ltd. Taiwan Branch " " Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited " |
Altek International Trading Co., Ltd. " Altek (Kunshan) Co., Ltd. " Altek Medical (Kunshan) Limited " Altek Corporation Altek Medical (Kunshan) Limited " Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. " |
(1) (1) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) |
Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Purchases Accounts payable Purchases Purchases Accounts payable |
7,983,832 $ 1,669,861 8,691,718 1,424,318 2,042,670 329,872 32,657 503,597 109,292 721,726 488,200 348,514 |
Net 120 days " Net 75 days " " " " " " " " " |
57% 10% 62% 9% 15% 2% 0% 4% 1% 5% 3% 2% |
Note 1: Relationship between transaction and counterparty is classified into the following categories:
(1) Parent company to subsidiary.
(2) Subsidiary to parent company.
(3) Subsidiary to subsidiary.
Note 2: Regarding percentage of transaction amount to consolidated total operating revenues or total assets, it is computed based on period-end balance of transaction to consolidated total assets for balance sheet accounts and based on accumulated transaction amount for the period to consolidated total operating revenues for income statement accounts.
Note 3: The Company may decide to disclose or not to disclose transaction details in this table based on the Materiality Principle.
Table 9
Altek Corporation
Information on investees
Table 10
Expressed in thousands of NTD (Except as otherwise indicated)
For the year ended December 31, 2022
| Investor | Investee | Location | Main business activities | Initial investment amount | Initial investment amount | Shares held as at December 31,2022 | Shares held as at December 31,2022 | Shares held as at December 31,2022 | Net profit (loss) of the investee for the year ended December 31,2022 |
Investment income(loss) recognised by the Company for the year ended December 31,2022 |
Footnote |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as at December 31, 2022 |
Balance as at December 31, 2021 |
Number of shares | Ownership (%) | Book value | |||||||
| Altek Corporation " " " " Altek International Investment Co., Ltd. " " " Altek International Holding (BVI) Co, Ltd. Altek Semiconductor (Cayman) Co., Ltd. Altek Medical Holding (Cayman) Co., Ltd. " Altek Investment |
Altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co, Ltd. Altek Investment Corporation Altek Medical Holding (Cayman) Co., Ltd. Altek Lab Inc. Altek Semiconductor (Cayman) Co., Ltd. Altek Optical Technology (Cayman) Co., Ltd. Altek International Trading Co,. Ltd. Altek Medical Holding (Cayman) Co. ,Ltd. Altek Semiconducton Corporation Altek Biotechnology Corporation Altek Medical (HongKong) Limited Ptek Corporation |
British Virgin Islands Japan British Virgin Islands Republic of China Cayman Islands U.S.A. Cayman Islands Cayman Islands Republic of Seychelles Cayman Islands Republic of China Republic of China HongKong Republic of China |
Investment Buying and saleing of electronic components Investment Investment Investment and general business operations Design service Investment Investment Intercompany transactions Investment and general business operations Research design and sales of ASIC Research and development, manufacture and sales of medical electronic equipments Investment Product development and design |
2,882,512 $ 2,869 415,376 100,000 755,272 113,005 188,781 406,785 307,100 - 350,000 115,376 36,852 3,000 |
2,882,512 $ 2,869 415,376 100,000 - 113,005 188,781 406,785 307,100 345,976 350,000 115,376 36,852 3,000 |
87,769,559 1,000 12,865,921 10,000,000 45,063,684 11,311,875 20,000,000 13,246,000 10,000,000 - 35,000,000 10,100,000 N/A 300,000 |
100 100 100 100 77.70 100 71.43 100 100 - 100 100 100 100 |
8,255,923 $ 10,190 1,270,802 99,796 875,644 64,320 89,078 134,496 244,222 - 126,277 717,786 70,826 2,865 |
216,609 $ 420 221,521 77) ( 357,395 74) ( 153,685) ( 42,290 9,196) ( 357,395 151,284) ( 194,439 34,474 132) ( |
210,635 $ 420 222,414 77) ( 65,146 74) ( 96,002) ( 42,290 9,196) ( 212,418 90,131) ( 151,079 26,787 132) ( |
Note 1 Note 2 Note 3 Note 1 Note 2 Note 2 Note 3 Note 2 Note 2 Note 2 |
Corporation
Note 1: The difference between the profit or loss of the investee for the current period and the investment profit or loss recognised in the current period is the unrealized profit and loss adjustments for countercurrent transactions between subsidiaries. Note 2: The difference between the profit and loss of the investee company in the current period and the investment profit and loss recognised in the current period is based on the shareholding ratio. Note 3: For investment structure adjustment, the shareholder of Altek Medical Holding (Cayman) Co., Ltd. was adjusted from Altek International Holding (BVI) Co., Ltd. to Altek Corporation in June, 2022.
Table 10
Information on investments in Mainland China
Table 11
Expressed in thousands of NTD (Except as otherwise indicated)
Altek Corporation
For the year ended December 31, 2022
| Investee in Mainland China |
Mainbusiness activities | Paid-incapital | Investment method (Note1) |
Accumulated amount of remittance from Taiwan to Mainland China as of January1,2022 |
Amount remitted from Taiwan to Mainland China/Amount remitted back to Taiwan for the year ended December31,2022 |
Accumulated amount of remittance from Taiwan toMainland China as of December31,2022 |
Net profit (loss) of investee for the year ended December31,2022 |
Ownership held by the Company (direct or indirect) |
Investment income (loss) recognised by the Company for the year ended December 31, 2022 (Note4) |
Accumulated amount of investment income remitted back to Taiwan as of December31,2022 Book value of investments in Mainland China as of December31,2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Remitted to Mainland China Remitted back to Taiwan |
||||||||||
| Altek (Kunshan) Co., Ltd. (Note 2) Altek EMS (Kunshan) Co., Ltd. (Note 3) Altek Trading (Shanghai) Limited Altek Precision (Kunshan) Co., Ltd. Altek Optical Technology (Kunshan) Co., Ltd. Altek Semiconductor (Shanghai) Co., Ltd. (Note 5) Altek Medical (Shanghai) Limited Altek Medical (Kunshan) Limited |
Manufacture and sale of digital still cameras and its accessories Production /sales of electronic product components Manufacture and sale of components for electronic related products Design, manufacture and sales of digital camera parts Manufacture and sale of components for electronic related products Research design and sales of imaging technologies, electronic software and hardware Sales of medical electronic equipment Manufacture and sale of medical electronic equipment |
1,523,216 $ 153,550 261,035 423,798 429,940 46,065 30,710 26,457 |
2 2 2 2 2 2 2 2 |
1,381,950 $ 278,939 261,035 423,798 408,443 - - - |
- $ - $ - - - - - - - - - - - - - - |
1,381,950 $ 278,939 261,035 423,798 408,443 - - - |
317,608 $ 13,070 5,030) ( 3,584 56,386 506) ( 34,477 34,758 |
100 100 100 100 75 100 78 78 |
317,608 $ 13,070 5,030) ( 3,584 42,290 1,199 26,789 27,007 |
4,592,660 $ - $ 584,226 91,860 302,342 - 158,152 - 134,493 - 110,557 - 64,688 - 61,243 - |
Note 1: Investment methods are classified into the following three categories; fill in the number of category each case belongs to:
(1)Directly invest in a company in Mainland China.
(2)Through investing in an existing company in the third area,which then investeed in the investee in Mainland China.
Note 2: Including retained earnings capitalized of US$4,600 (In thousand of US dollars).
Note 3: Including retained earnings capitalized of US$3,600 (In thousand of US dollars). Note 4: Investment income or loss was recognised in the financial statements that are audited by the R.O.C parent company's independent auditors. Note 5:In June 2022, the investment structure of the subsidiary Altek Semiconductor (Shanghai) Co., Ltd. was adjusted, and the shares of Altek Semiconductor (Cayman) Co., Ltd. were adjusted to the shares of Altek Trading (Shanghai) Limited.
Company name
Altek Corporation
Accumulated amount of remittance from Taiwan to Mainland China as of December 31, 2021
$2,754,165
Investment amount approved by the Investment Commission of the Ministry of Economic Affairs (MOEA)
$3,113,185
Ceiling on investments in Mainland China imposed by the Investment Commission of MOEA
$5,317,837
Table 11
Altek Corporation Information of major shareholders December 31, 2022
Table 12
| Name of major shareholders | Shares | Shares |
|---|---|---|
| Number of shares held | Holding percentage | |
| Yitsang International Co., Ltd. | 14,630,100 | 5.24% |
Table 12